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The re-emergence of Zika virus (ZIKV) in 2015 as a significant human pathogen 
causing neurological diseases in infants as well as adults is a serious global health 
concern. A clear understanding of the mechanisms involved in ZIKV replication in 
infected host cells as well as the host responses to virus infection are keys to the 
development of therapeutic strategies against ZIKV. Studies conducted in this 
dissertation demonstrate that ZIKV infection induces the activation of mTOR signaling 
cascade that promotes viral protein accumulation and infectious progeny production. 
While both mTORC1 and mTORC2 are essential for ZIKV replication, the observation 
that depletion of Raptor, the unique component of mTORC1, imposes a robust negative 
effect on ZIKV protein expression and progeny production also suggests a mTOR-
independent role played by Raptor. Additionally, the activation of autophagy at early 
times of infection indicates an antiviral role for autophagy in ZIKV infection. The 
observation that pharmacological inhibition of autophagy led to increased accumulation 
of ZIKV proteins further strengthens this contention. Since infection-induced oxidative 
stress contributes to ZIKV pathogenesis, studies reported in this dissertation also show 
that ZIKV infection alters the redox homeostasis in infected cells and triggers Nrf2-
mediated antioxidant response. Depletion of Nrf2 downregulates the cellular pool of GSH 
and NADPH leading to enhanced ZIKV replication thereby underscores a role for cellular 
antioxidants in the suppression of ZIKV replication. The dependency of ZIKV replication 
on host cell glycolysis is highlighted by significant reduction in viral protein expression 
and virus yield due to pharmacologic inhibition. When glycolysis is inhibited, 
gluconeogenesis was found to facilitate ZIKV replication by compensating carbon input 
via oxidative mitochondrial metabolism. Further experimentation comparing the 
metabolic profiles of mock- and ZIKV-infected cells may provide important information 
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CHAPTER 1: INTRODUCTION 
 
1.1 Zika virus (ZIKV): Discovery, history, and re-emergence 
In 1947, scientists isolated a filterable and previously unrecorded virus from the 
serum of a pyrexial rhesus monkey in the Zika forest of Kampala, Uganda (Dick et al., 
1952). The following year, in 1948, a second isolation of the same virus was made from 
Aedes africanus mosquitoes (Dick et al., 1952). Cross neutralization tests showed 
evidence of a novel virus that was not identical to yellow fever virus (YFV) or Theiler's 
mouse encephalomyelitis virus that were prevalent in that region. Owing to the location 
of its discovery, this novel virus was named Zika virus (ZIKV) (Dick et al., 1952; Musso 
and Gubler, 2016). While seropositivity in humans was reported in Tanzania and Uganda 
in 1952, the first case of human infection with ZIKV was reported in 1954 in Nigeria 
(Macnamara, 1954; Musso and Gubler, 2016). The virus was isolated from Aedes aegypti 
mosquitos in Malaysia in 1969 and the first case of human infection outside of the 
African continent was reported in Central Java, Indonesia (Musso and Gubler, 2016). 
Since its discovery, only about 14 cases of human infection were reported in Asia and 
Africa (Kindhauser et al., 2016; Musso and Gubler, 2016; Sharma et al., 2017) (Fig. 1.1).  
After almost 60 years, in 2007, the virus re-merged and about 72.6% of the population 
was infected causing a major epidemic in the Yap Island of Federated States of 
Micronesia (Kindhauser et al., 2016). A second outbreak affecting about 11.5% of the 
population occurred in 2013 in French Polynesia. Additional smaller outbreaks also 
occurred in other Pacific Islands such as New Caledonia, Cook Islands, and Easter Island 
in 2013-14 (Cao-Lormeau et al., 2014; Musso and Gubler, 2016; Musso et al., 2014). In 









Figure 1.1: Global presence of ZIKV. A Worldwide spread of ZIKV from 1947 to 2016 
(Image sourced from Lessler et al, 2016). B ZIKV in the USA and its territories: 
Numbers of laboratory-confirmed symptomatic Zika virus infections reported to 
ArboNET by US states and territories as of 2017 and C 2021. ZIKV infections in the US 
and its territories have significantly declined in the past three years [Image sourced from 
the Centers for Disease Control and Prevention (CDC), National Center for Emerging 





spread the Americas and other parts of the world (Kazmi et al., 2020; Zanluca et al., 
2015). In the United States of America, the Center for Disease Control and Prevention 
(CDC) reported about 5,746 symptomatic infections till 2019 with most of them 
associated with travelling to places where ZIKV was actively spreading. The CDC also 
reported about 37,000 cases in US territories (Fig. 1.1). Globally, the virus has been 
reported in more than 84 countries and the recent outbreaks in the Americas have been 
associated with increased instances of Guillain-Barré Syndrome (GBS) in adults and 
microcephaly in neonates (Maslow and Roberts, 2020). Although only a few cases of 
transmission of ZIKV have been reported since 2017, it has the potential to cause major 
outbreaks in the future (Musso et al., 2019). 
 
1.2 ZIKV: Classification 
ZIKV belongs to the family Flaviviridae and genus flavivirus. The Flaviviridae 
family consists of four genera: Flavivirus, Pestivirus, Hepacivirus and Pegivirus (2017). 
The genus Flavivirus comprises of over 70 arthropod-borne viruses. Further classification 
of flaviviruses is based on the arthropod vector utilized by them. Viruses like ZIKV, 
Dengue virus (DENV), Yellow Fever Virus (YFV), Japanese Encephalitis (JEV) and 
West Nile virus (WNV) are transmitted by mosquitoes (Kuno et al., 1998). Viruses like 
Kyasanur Forest Disease virus (KFDV), Tick-borne Encephalitis virus (TBEV), Omsk 
Hemorrhagic Fever Virus (OHFV) and Alkhurma virus (ALKV), which are responsible 
for encephalitis and hemorrhagic diseases, are transmitted by ticks. 
 
1.3 ZIKV: Virion structure 
5 
 
 The cryo-EM structure at near atomic resolution (3.8Å and 3.7Å) of ZIKV was 
solved by two independent groups and was found to be consistent with other closely 
related flaviviruses such as DENV and WNV (Kostyuchenko et al., 2016; Sirohi et al., 
2016). As depicted in Fig. 1.2, the immature virion is  ~60nm in diameter while a mature 
ZIKV particle is ~50nm in diameter (Kostyuchenko et al., 2016; Prasad et al., 2017; 
Sirohi et al., 2016; Sirohi and Kuhn, 2017). The viral genome is a single-stranded, 
positive-sense and non-segmented RNA of about 11 kilobases and is encapsulated by the 
viral capsid protein and the host derived lipid bilayer (Boyer et al., 2018) (Fig. 1.2). 
A mature ZIKV virion contains 180 copies of the viral E and M proteins that are 
embedded in the host derived lipid membrane (Sirohi and Kuhn, 2017). The E protein 
consists of 4 domains, namely, ectodomains I, II and III (DI, DII, DIII) and a stem-
transmembrane domain. The surface of the virion is covered by the E protein while the M 
protein resides beneath the E protein and is attached by a small extra-cellular region 
(Sirohi and Kuhn, 2017). The E protein is organized as a dimer and 3 such dimers are 
arranged in parallel to form a raft configuration. There are 30 rafts in a single ZIKV 
particle (Sirohi and Kuhn, 2017). ZIKV does not exhibit the usual T=3 quasi-equivalence 
even with 180 units of E and M proteins arranged in a raft configuration. This is because 
of the unusual arrangement of the E protein (Sirohi and Kuhn, 2017). 
 
1.4 ZIKV: Genome organization 
The infectious genome of ZIKV is a single-stranded, positive-sense RNA of about  
11 kb in length and is arranged in the following order: 5’ untranslated region (UTR), a 




Figure 1.2: Structure of Zika virus particles. Immature and mature ZIKV particles. 
Proteolytic processing of prM protein, by host protease furin, in the immature non-
infectious virion A results in the generation of mature, smooth-surfaced, infectious 
particle B. The immature particle contains 60 trimers of prM-E heterodimers, while the 
mature particle contains 90 conformationally rearranged heterodimers of M-E (Images 
were adapted from Sirohi, D. and Kuhn, R.J. (2017)). C Schematic representation of a 
prototypical flavivirus (including Zika virus) immature and mature particle showing a 
cross-sectional organization of viral proteins and RNA. sE, soluble E protein [Image 





5’ UTR is  ~106 nucleotides long and has a type I cap (m7GpppAmp) structure at the 5’ 
terminus and is followed by conserved AG dinucleotide (Brinton and Dispoto, 1988). The 
3’ UTR comprises of  ~430 nucleotides and does not have a poly A tail but ends with 
consists of conserved CUOH at the 3 ’-terminus (Brinton et al., 1986) (Fig. 1.3). 
The ORF is ~10.2 kilobases and is translated into a single polypeptide of ~3400 
amino acids in the cytoplasm of an infected cell (Chambers et al., 1990). The single 
polypeptide is processed and cleaved by proteases of host as well as viral origin and 
results in three amino-terminal structural (capsid, C; pre-membrane, prM; and envelope, 
E) proteins and seven carboxy-terminal non-structural (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, and NS5) proteins (Kuno and Chang, 2007) (Fig. 1.3). As in other flaviviruses 
like DENV, WNV, YFV and JEV, the structural proteins are responsible for virus 
attachment and entry into host cells, and virion formation while the non-structural 
proteins aid in genome replication, polypeptide processing, evasion of host antiviral 
defenses and virion assembly (Diamond and Pierson, 2015; Kumar et al., 2016). 
 
1.5 ZIKV: Structural proteins 
1.5.1 Capsid (C) protein  
The C protein is 104 aa in length and has a molecular weight of ~14 kDa (Shang 
et al., 2018). Following translation, the protein relocates to the cytoplasmic side of the ER 
and helps in the translocation of the viral prM protein into the ER lumen (Byk and 
Gamarnik, 2016; Tan et al., 2020). It has an overall positive charge and associates with 
the negatively charged genomic RNA forming the nucleocapsid core which gets 





Figure 1.3: ZIKV genome organization, encoded proteins, and their topology. A The 
viral genome is shown as a red line with a cap structure at the 5’ end, followed by an 
untranslated region (5’UTR), various proteins (with amino acid residue length) generated 
from a single ORF that is translated from the genome, and the 3’ UTR. B Topology of the 
viral proteins. Arrows show various protease cleavage sites for generation of the mature 
proteins. A small protein (2K) present between NS4A and NS4B is membrane-
associated. The cylindrical structures represent membrane-associated domains of the 
proteins (Image redrawn from Tan et al, 2020)  
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play a vital role in the process of virus assembly and is responsible for the overall 
icosahedral structure of the virus particle (Tan et al., 2020). Additionally, the capsid 
protein is known to translocate into the nucleus of the infected cells and interfere with 
ribosome biogenesis and alter host transcriptome (Sotcheff and Routh, 2020). 
 
1.5.2 Precursor membrane (prM) and membrane (M) proteins  
The prM protein is a glycosylated protein of 168 aa in length (Kuno and Chang, 
2007). Post synthesis, the prM protein relocates into the ER where, and in association 
with the viral envelope protein, forms immature virions and acts a chaperone for efficient 
and proper folding of the envelope protein (Lorenz et al., 2002; Nambala and Su, 2018; 
Nambala et al., 2020). The prM protein is cleaved by cellular furin protease in the trans-
golgi network and results in pr peptide and the M protein (Hsieh et al., 2011). The pr 
peptide associates with the envelope protein and helps in egress of mature virus particles 
(Oliveira et al., 2017). Recent studies suggest that the prM protein plays a significant role 
in increased neurovirulence and the development of microcephaly in mice (Yuan et al., 
2017). The study also found that a serine to asparagine aa substitution (S139N) in the 
prM protein of ZIKV resulted in a more infectious phenotype while a reverse mutation 
(N139S) produced a less infectious virus (Yuan et al., 2017).  
 
1.5.3 Envelope (E) protein 
The envelope protein is the outermost covering of a ZIKV particle, 504 aa in 
length and has a molecular weight of ~53 kDa (Dai et al., 2016). It has a single 
glycosylation site at position 154 (N154) (Annamalai et al., 2017; Carbaugh et al., 2019; 
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Routhu et al., 2019). Flaviviral E protein plays a significant role in recognition of host 
cell receptor, membrane fusion, viral entry into the host cell and assembly of progeny 
virions (Cruz-Oliveira et al., 2015; Valente and Moraes, 2019). It is cleaved by host 
signal peptidase from the translated polyprotein in the ER lumen following which hetero-
dimerization of E and prM occurs (Dai et al., 2016). The E protein consists of three major 
domains: DI, DII, and DIII out of which EDIII is a major target for potent flavivirus type-
specific neutralizing antibodies (mAb) (Beltramello et al., 2010; Dai et al., 2016). The 
highly conserved fusion loop epitope  (FLE) in DII is also a target for less potent cross-
neutralizing mAbs (Beltramello et al., 2010; Costin et al., 2013). 
 
1.6 ZIKV: Nonstructural (NS) proteins 
1.6.1 Non-structural protein 1 (NS1) 
The non-structural protein 1 (NS1) of ZIKV is a 352 aa long glycoprotein. As 
with most mosquito-borne flaviviruses, ZIKV NS1 has 2 conserved glycosylation sites 
(Pryor and Wright, 1994). Depending on the glycosylation pattern, its molecular weight 
ranges between 46 to 54 kDa (Muller and Young, 2013; Rastogi et al., 2016). Zika virus 
NS1 protein shares structural similarity to related flaviviruses like DENV2 and WNV 
(Muller and Young, 2013; Xu et al., 2016). NS1 exists in multiple locations in a cell. It is 
found to be associated with intracellular vesicular compartments induced by virus 
infection, on the surface of the infected cell and as a soluble lipoparticle that is secreted 
(Muller and Young, 2013). Intracellular NS1 exists as a dimer and is associated with 
vesicular compartments (Winkler et al., 1988). It functions as an essential cofactor in 
virus replication and is found to co-localize with double-stranded RNA (dsRNA) 
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(Mackenzie et al., 1996). The secreted form of NS1 forms a hexamer and is known to be 
highly immunogenic. It has also been shown to interact with host factors and contributes 
to disease pathogenesis (Avirutnan et al., 2006; Muller and Young, 2013). Studies with 
several flaviviruses have suggested that NS1 protein glycosylation plays a critical role in 
viral genome replication and pathogeneis (Annamalai et al., 2019; Pletnev et al., 1993; 
Pryor et al., 1998; Pryor and Wright, 1994).  
 
1.6.2 Non-structural protein 2 (NS2) 
Proteolytic cleavage of ZIKV NS2 from the single polypeptide results in 2 
proteins: NS2A and NS2B. While NS2A is 226 aa in length, NS2B is 130 aa long (Sirohi 
and Kuhn, 2017). Following proteolytic cleavage, NS2A relocates to the endoplasmic 
reticulum (ER) where it is an essential component of viral replication complex (Xie et al., 
2013). Additionally, it also helps in progeny virion assembly and downregulation of host 
immune response (Xie et al., 2013). NS2B is a critical component of a so called ‘two-
component protease’ and is essential to the proper functioning of the NS3 protein (Gupta 
et al., 2015).  
 
1.6.3 Non-structural protein 3 (NS3) 
 Flaviviral NS3 protein is one of the largest proteins and is ~617 aa in  length 
(Brecher et al., 2013). It has 2 domains: i) N-terminal serine protease (NS3Pro) domain, 
and ii) C-terminal RNA helicase (NS3Hel) and triphosphatase (NS3RTPase) domain 
(Brecher et al., 2013; Li et al., 1999; Warrener et al., 1993). It has been shown that the 
association of NS2B with NS3 results in the proteolytic cleavage of NS3 and the 
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formation of an active serine protease complex which serves a critical role in flavivirus 
replication and progeny virion assembly (Arias et al., 1993; Chambers et al., 1991; 
Chambers et al., 1993). The flaviviral NS2B-NS3 protease complex is highly conserved 
and is a potential target for the development of inhibitors against flaviviruses (Li et al., 
2017b; Li et al., 2018). 
 
1.6.4 Non-structural protein 4 (NS4) 
 Like NS2, flavivirus NS4 is processed to generate NS4A and NS4B, with an 
additional highly hydrophobic 2K peptide that is located between them (Sirohi and Kuhn, 
2017). NS4A is 127 aa long and is an important viral protein that remains associated with 
cellular membranes and is involved in membrane rearrangements and the formation of 
viral replication complexes (Miller et al., 2007; Roosendaal et al., 2006). Additionally, it 
has also been demonstrated that ZIKV NS4A inhibits the interaction of RLR-MAVS and 
impairs antiviral immune responses (Ma et al., 2018). NS4B is 251 aa in length and has 
been shown to interfere with host type-I interferon response by blocking the activation of 
STAT1 (Gerold et al., 2017; Munoz-Jordan et al., 2005). Both ZIKV NS4A and NS4B 
have been shown to interfere with the Akt-mTOR axis of signaling and induce autophagy 
in human neural stem cells (Liang et al., 2016). Addittionaly, inhibition of the Akt-
mTOR axis, a key signaling pathway involved in neuronal development, along with the 
activation of autophagy can be a potential mechanism by which ZIKV induces 
microcephaly (Liang et al., 2016). 
 
1.6.5 Non-structural protein 5 (NS5) 
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Flaviviral NS5 is 903 aa in length and is the largest and the most conserved of all 
the proteins (Song et al., 2021). It has two domains: i) a C-terminal RNA-dependent 
RNA polymerase (RdRp) domain, and ii) a N-terminal methyltransferase (MTase) 
domain (Elshahawi et al., 2019; Song et al., 2021). While the RdRp domain aides in de 
novo viral RNA synthesis, the MTase domain contributes to methylation of the RNA cap 
to form N-7-methyl-guanosine and 2’-O-methyl-adenosine using S-adenosyl-L-
methionine (SAM) as the methyl donor (Godoy et al., 2017; Zhang et al., 2017). In 
addition to viral genome replication, NS5 also contributes to immune evasion. A recent 
report demonstrated that ZIKV NS5 interacts with host retinoic acid-inducible gene I 
(RIG-I) and prevents the nuclear translocation of interferon regulatory factor 3 (IRF3) 
resulting in inhibition of interferon-β (IFN-β) production and signaling (Li et al., 2020). 
 
1.7 Life cycle of ZIKV 
 ZIKV reservoir is maintained in mosquitoes and is transmitted to humans by 
infected female Aedes mosquitoes while feeding for blood. Following this, the virus 
interacts with several cell surface receptors like dendritic-cell-specific intercellular 
adhesion molecule-3-grabbing non-integrin (DC-SIGN) (Pierson and Diamond, 2020; 
Tassaneetrithep et al., 2003), Tyro3, Axl and Mertk (TAM) family of phosphatidylserine 
receptors (Meertens et al., 2012; Perera-Lecoin et al., 2013) and/or  T-cell 
immunoglobulin domain and mucin domain (TIM) (Meertens et al., 2012; Pierson and 
Diamond, 2020) and infects skin cells such as dermal epidermal keratinocytes, 
fibroblasts, and immature dendritic cells (Hamel et al., 2015). The virus then infects 




Figure 1.4: Replication of ZIKV in host cells. The virus enters host cells by receptor-
mediated endocytosis and fuses its membrane by an acidic-pH-triggered mechanism in 
the endosome to release the viral RNA. The positive-stranded genomic RNA serves as 
the only viral mRNA and leads to the synthesis of a polyprotein that is co- and post 
translationally processed into three structural and seven nonstructural proteins. Virus 
assembly takes place at the ER membrane and leads to the formation of immature virions, 
which are further transported through the TGN that causes structural changes allowing 
the cleavage of prM by the cellular protease, furin. The mature virions are transported to 




to other organs in the body such as the reproductive organs, the placenta, the brain and 
spinal cord (Miner and Diamond, 2017). 
Following interaction of the virus with cell surface receptor(s), clathrin-mediated 
endocytosis internalizes the virion (Hackett and Cherry, 2018) and delivers to an early 
endosome where the viral E protein undergoes structural modifications due to an acidic 
environment (Perera-Lecoin et al., 2013). This is followed by the fusion of the endosomal 
membrane with the viral envelope and release of the viral genomic RNA into the cytosol 
(Pierson and Diamond, 2020) (Fig. 1.4). 
Once inside a cell, ZIKV follows a similar chain of events as other members of 
the Flaviviridae family. The genomic RNA serves as an mRNA template for cap 
dependent translation which is initiated as soon as the genomic RNA is released into the 
cytosol (Barrows et al., 2018). It encodes a single open reading frame that is flanked by a  
5’ and 3’ UTR (Pierson and Diamond, 2020). The presence of the ER-localization signal 
at the carboxy-terminal end of the C protein promotes its translocation to the ER 
membrane where it rapidly associates with the ribosomes leading to co-translation and 
insertion of the polyprotein into the ER lumen where the synthesis of nascent viral 
proteins occurs. The nascent proteins are then cleaved by host and viral proteases to 
generate the mature structural and non-structural proteins (Sager et al., 2018). The  
flanking UTRs aide in translation of the viral RNA, replication, and subversion of host 
immune response (Gebhard et al., 2011). The translation of viral proteins primes the host 
environment for viral genomic RNA replication which occurs in endoplasmic reticulum 
(ER) derived membrane-bound structures called replication compartments (RCs)  
(Aktepe and Mackenzie, 2018; Barrows et al., 2018). The ultrastructure of such RCs has 
16 
 
been solved using cryo-EM tomography which shows spherical structures budding from 
the cytosolic face of the ER and containing all the components necessary for viral RNA 
replication and progeny virion assembly (Aktepe and Mackenzie, 2018; Pierson and 
Diamond, 2020; Welsch et al., 2009). Apart from serving as the template for the synthesis 
of viral proteins, the genomic RNA also serves as a template for RNA synthesis. The first 
step involves the synthesis of a negative-sense RNA resulting in the formation of dsRNA 
intermediate from which the positive-sense viral genome is produced (Lindenbach and 
Rice, 2003). Along with the newly synthesized viral proteins, the positive-strand RNA is 
packaged into progeny virus particles at the surface of the ER. These immature progeny 
virions then bud from the ER surface and are transported into the TGN where the prM 
protein is cleaved by furin-like proteases (Tomar et al., 2017; Wang et al., 2017). This is 
followed by the homodimerization of the E protein resulting in mature virions which are 
then released from the cell by exocytosis (Nambala et al., 2020) (Fig. 1.4). 
 
1.8 ZIKV: Clinical Disease 
In general, the clinical presentation of flavivirus infection in humans ranges from 
mild illness that includes asymptomatic infection or episodes of self-limiting fevers to 
severe and life-threating conditions including shock syndrome, haemorrhagic fever, 
encephalitis, congenital defects, and hepatitis (Pierson and Diamond, 2020). While 
majority of flavivirus, including ZIKV, infections do not present with any symptoms 
(Musso et al., 2018; Musso and Gubler, 2016), a fraction of infected individuals may 
present with symptoms including but not limited to conjunctivitis, myalgia, headache, 
arthralgia and a rash that do not have any long-term consequences (Antoniou et al., 2020; 
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Burger-Calderon et al., 2018; Pierson and Diamond, 2020). However, in 2015, the ZIKV 
outbreak in Brazil caused major concern because of its association with microcephaly, 
fetal growth retardation, brain malformations, and other neurological disorders, 
collectively termed as congenital Zika syndrome (CZS)  in infants and Guillain-Barré 
syndrome in adults (Cao-Lormeau et al., 2016; Coyne and Lazear, 2016; Heukelbach et 
al., 2016; Miner and Diamond, 2017; Rawal et al., 2016; Wheeler, 2018). 
Microcephaly is a congenital abnormality in which the size of the head of the 
fetus is smaller than the average head size of infants in the same age and sex group 
(Antoniou et al., 2020) and such a condition is associated with reduced brain size and 
developmental disabilities (Heukelbach et al., 2016) (Fig. 1.5). Microcephaly can occur 
because of i) failure of the brain to grow appropriately during pregnancy due to reduced 
neuron production, called congenital microcephaly, or ii) failure to develop post-partum 
due to loss of dendritic connections, called secondary or postnatal microcephaly 
(Barbelanne and Tsang, 2014; Faizan et al., 2016). The 2015 outbreak in Brazil saw an 
increased incidence of infants born with congenital microcephaly where pregnant women 
were diagnosed positive for ZIKV infection (Antoniou et al., 2020; Heukelbach et al., 
2016). Apart from that, ZIKV infection have also been associated, albeit infrequently, 
with organ failures, subcutaneous bleeding and thrombocytopenia, encephalitis, and  
meningitis (Carteaux et al., 2016; Karimi et al., 2016; Pierson and Diamond, 2018; 
Swaminathan et al., 2016). Additionally, very few cases of death have been reported in 
children with sickle cell anemia who were infected with ZIKV (Pierson and Diamond, 





Figure 1.5: Association of ZIKV infection and microcephaly. The circumference of 
the head is compared between a healthy infant and an infant suffering from microcephaly. 
Severe reduction in the size of the head along with developmental deficits is seen 
newborn children suffering from congenital microcephaly. The 2015-16 ZIKV outbreak 
in Brazil has been associated with an increased incidence of children born with 





1.8.1 Association of ZIKV with microcephaly 
The reemergence of ZIKV in 2015 as a potential pathogen that caused serious 
developmental disorders redirected the scientific community to focus on investigating its 
causal role in microcephaly. This was borne out of the observation that ZIKV was found 
in the brain tissues of the fetuses suffering from microcephaly in women who, during the 
first trimester of pregnancy, were infected with the virus (Driggers et al., 2016; Mlakar et 
al., 2016). While, initially, it was unclear whether ZIKV targeted mature neurons or 
progenitor cells that would eventually proliferate and differentiate into mature neurons, 
several studies revealed that ZIKV directly targeted the cortical neural progenitor cells 
leading to cell death (Li et al., 2016b; Tang et al., 2016). These findings provided 
evidence for the Centers for Disease Control and Prevention (CDC) to declare that ZIKV 
can cause microcephaly (Rasmussen et al., 2016). Additionally, the findings that not only 
can ZIKV be transmitted via mosquitoes but can also be transmitted sexually between 
individuals as well as vertically, from mother to the fetus, led to increased public 
concerns (Christian et al., 2019; D'Ortenzio et al., 2016).  
Although a direct understanding of the molecular mechanisms of ZIKV-induced 
microcephaly is yet to be established, a number of reports have described several 
probable mechanisms that may contribute to neurological deficits in developing brains. 
One of the probable mechanisms is the accumulation of several nucleotide mutations in 
key viral proteins that are involved in immune evasion (Mlakar et al., 2016). When 
compared with the French Polynesian strain, the Brazilian strain contains three mutations 
in the NS1 protein at sites K940E, T1027A, and M1143V which are implicated in 
immune evasion (Mlakar et al., 2016; Wen et al., 2017). Additionally, a mutation in 
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NS4B at T2509I, implicated in the inhibition of type I interferon signaling and in NS5 at 
M2634V, implicated in the masking of the viral RNAs from recognition by the host, also 
tend to contribute to the development of microcephaly (Mlakar et al., 2016). Another 
report demonstrated that a single nucleotide mutation in the prM protein (S139N) lead to 
increased virulence in mice and human neural progenitor cells (NPCs) and resulted in 
more severe microcephaly and fetal demise in neonatal mice (Yuan et al., 2017). 
Furthermore, the failure of host exonucleases to degrade subgenomic flaviviral RNAs 
(sfRNAs) produced in the 3’ UTRs results in their accumulation in the cytosol and are 
known to contribute to pathologic effects (Akiyama et al., 2016). Such observations can 
explain the unprecedented emergence of ZIKV and its association with neurological 
complications in the recent times. 
Another potential mechanism for ZIKV-induced microcephaly can be attributed 
to tissue tropism, i.e., the ability of the virus to infect specific types of cells and tissues. 
ZIKV has been shown to preferentially infect neural progenitor cells and induce 
apoptosis resulting in their depletion (Dang et al., 2016; Tang et al., 2016). Mature 
neurons are also infected by the virus albeit to a lesser extent (Tang et al., 2016). This 
phenomenon can very likely cause neurodevelopmental deficits. Indeed, when 
developing wild type mice fetuses were infected with ZIKV by intra-ventricular 
injections, differentiation of neural progenitor cells was significantly inhibited and this 
resulted in the development of microcephaly (Li et al., 2016a). Additionally, with direct 
intracranial inoculation of ZIKV in early post-natal wild-type mice pups depleted 




While mouse models played a significant role in the initial studies needed to 
establish the causal role of ZIKV for microcephaly, later studies in human brain organoid 
cultures provided a much better understanding of the effect ZIKV infection in a more 
relevant model system. Several groups have reprogrammed human pluripotent stem cells 
(hPSCs) that can be induced and developed into three dimensional (3-D) organoids which 
can be used as a more relevant model system to study specific aspects of brain 
development and ZIKV pathogenesis (Lancaster et al., 2013; Qian et al., 2016). In 
corroboration with the findings from mouse models, ZIKV infection of human 
neurosphere organoid cultures in vitro was shown to induce cell death (Garcez et al., 
2016). Using such models, it has been shown that ZIKV infection induces pre-mature 
differentiation of neural progenitor cells, leads to cell death, and can produce phenotypes 
of microcephaly (Dang et al., 2016; Gabriel et al., 2017). ZIKV infection in the first 
trimester of pregnancy has been shown to result in developmental deficits in the brain and 
microcephaly in the fetus (Driggers et al., 2016; Mlakar et al., 2016; Olagnier et al., 
2016). Hofbauer cells (placental macrophages) and to a lesser extent, cytotrophoblasts, in 
the placenta are the main targets of  ZIKV and this leads to vertical transmission of ZIKV 
from mother to the developing fetus (Quicke et al., 2016).  
In addition to cell-autonomous effects of ZIKV infection on hNPCs, bystander 
effect is also seen and may contribute to ZIKV induced pathogenesis (Christian et al., 
2019). In a 20-week old fetus with intra-uterine ZIKV infection, cell death by apoptosis 
was seen in infected as well as uninfected bystander cortical neurons which was likely 
due to neurotoxic factors including interleukin 1 β (IL1-β), and tumor necrosis factor α 
(TNFα) secreted by the infected cells (Olmo et al., 2017). Additionally, glial cells and 
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microglia (resident macrophages) act as viral reservoirs and also play a bystander role in 
ZIKV induced disease. Microglia have been reported to be direct targets of ZIKV 
infection as shown in the examination of brain tissue from aborted fetuses (Lum et al., 
2017). The proliferation of NPCs was found to be inhibited when they were grown in 
conditioned media taken from infected primary microglia (Wang et al., 2018). 
Furthermore, co-culturing of ZIKV-infected microglia and NPCs resulted in the spread of 
infection to the NPCs resulting in cell death (Mesci et al., 2018). In human induced 
pleuripotent stem cells (hiPSCs) derived populations, ZIKV successfully infected a 
variety of cells like astrocytes, microglia-like cells and hNPCs but cell death by apoptosis 
was only seen hNPCs (Muffat et al., 2018). Another study reported that infection of  
human fetal neural stem cells (fNSCs) induces autophagy and subsequent cell death by 
impairing the Akt/mTOR signaling cascade (Liang et al., 2016). 
 
1.9 mTOR signaling cascade 
Virus replication in host cells requires modulation of host cell pathways such as 
energy metabolism and macromolecule synthesis as well as inhibiting antiviral responses 
leading to production of viral progeny by the host cell machinery. The mechanistic 
(formerly, called mammalian) target of rapamycin (mTOR) signaling cascade is critical 
to the regulation of various cellular and metabolic processes including gene expression, 
protein translation, cell proliferation, cell survival, autophagy, etc. (Foster and Fingar, 
2010; Saxton and Sabatini, 2017b) (Fig. 1.6).  The mTOR kinase is an evolutionarily 






Figure 1.6: The mTOR cascade. Schematic showing the activation of mTORC1 leading 
to protein synthesis, cell growth and proliferation and the inhibition of autophagy. The 
phosphorylation of Akt at Ser 473 and Thr 308 by mTORC2 and PI3K activates it which 
in turn phosphorylates and activates mTORC1. This leads to the phosphorylation of 
P70S6K at Thr389, that regulates cell growth and cell cycle progression, and 4EBP1 at 
multiple sites, that regulates the translation of mRNAs and cell proliferation. Activated 
mTORC1 also phosphorylates ULK1 at Ser 757 resulting in the inhibition of ULK 1 




mTOR complex (mTORC) 1 and mTORC2 (Foster and Fingar, 2010; Saxton and 
Sabatini, 2017b). Each complex responds to different environmental stressors and has 
unique regulatory properties, as well as cellular activities. The regulatory associated 
protein of mTOR (Raptor) and the rapamycin insensitive companion of mTOR (Rictor) 
are essential and distinguishing subunits of the mTORC1 and mTORC2, respectively and 
act as scaffold proteins to assemble and stabilize respective complexes (Saxton and 
Sabatini, 2017b; Yang et al., 2013). The phosphorylation and activation of downstream 
effectors of mTORC1, the p70 ribosomal S6 kinase 1 (p70S6K), the eukaryotic initiation 
factor 4E (eIF4E)-binding protein 1 (4EBP1), and Unc-51 like autophagy activating 
kinase 1 (ULK1) regulate cap-dependent mRNA translation, metabolism, and 
protein/organelle quality control mechanisms via autophagy (Saxton and Sabatini, 2017b; 
Yang et al., 2013). In conditions of abundant nutrients, mTORC1 triggers ribosome 
assembly and translation of mRNA leading to cellular growth and proliferation, and 
inhibition of autophagy (Le Sage et al., 2016). On the other hand, the regulation of 
mTORC2 is not fully understood, but is known to associate with the ribosomes and that 
this association is triggered primarily by insulin-stimulated phosphatidylinositol 3-kinase 
(PI3K) signaling (Zinzalla et al., 2011). mTORC2 phosphorylates several proteins of the 
AGC family of kinases such as protein kinase C (PKC), protein kinase B (PKB/Akt), and 
the serum and glucocorticoid induced kinases (SGK) regulating various aspects of 
cytoskeletal structure modelling and cellular survival (Saxton and Sabatini, 2017b). 
  
The mTOR cascade can be activated by multiple extracellular stressors that bind 
to cell surface receptors which transduce the signal to PI3K (Le Sage et al., 2016). This 
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results in the phosphorylation of the growth factor-activated kinase, Akt, at threonine308 
(Thr308) and subsequently at serine 473 (Ser473) by mTORC2 resulting in its activation 
(Le Sage et al., 2016; Sarbassov et al., 2005). An activated Akt phosphorylates tuberous 
sclerosis protein 2 (TSC2) leading to the conversion of Rheb-GDP to Rheb-GTP resulting 
in the activation of mTORC1 (Inoki et al., 2002; Menon et al., 2014) (Fig. 1.6). In 
contrast, several intracellular and extracellular stimuli such as energy deficit, generation 
of reactive oxygen species (ROS) and growth factor deficiency can inhibit the mTOR 
cascade (Huang and Manning, 2009; Wang and Proud, 2011). Viruses including ZIKV 
are also known to manipulate the mTOR signaling cascade to support their optimal 
replication and pathogenic potential.  
 
1.9.1 mTOR and microcephaly 
mTOR signaling plays a very important role the proper development and 
functioning of the brain and is key to phenomena such as neural stem cells proliferation, 
spatio-temporal organization, migration and differentiation of neurons, assembly and 
maintenance of neural circuits as well as regulation of complex behaviors such as 
sleeping, feeding, and maintenance of circadian rhythms (Lipton and Sahin, 2014). The 
mTOR signaling cascade is tightly regulated in proper brain development and any 
abnormality or impairment has been implicated in several neurodegenerative diseases 
(Lipton and Sahin, 2014). It has been observed that while early loss of mTOR function in 
brain development leads to death and exhaustion of progenitor cells that are necessary for 
proper brain development, over-activation may also be catastrophic and lead to rapid 
exhaustion of stem cell niches resulting in serious pathological consequences (Lipton and 
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Sahin, 2014). Studies done with a conditional mutant of mTOR demonstrated that while 
early activation of the cascade induced microcephaly, delayed activation in post-mitotic 
neurons lead to cortical hypertrophy, neuro-degeneration, and early death in mice (Kassai 
et al., 2014). Attempts to dissect the roles of mTORC1 and mTORC2 by Rictor and 
Raptor specific knockouts demonstrated that while Rictor knockouts that were specific to 
the brain led to reduced neuronal size, shorter dendritic processes and smaller brains, 
brain-specific Raptor knockouts resulted in reduced cell size and death, inhibition of 
gliogenesis, and post-natal fetal demise (Cloetta et al., 2013; Thomanetz et al., 2013).  
 
1.9.2 mTOR and autophagy 
Apart from regulating cell proliferation, cellular metabolism, energy metabolism 
and macromolecule synthesis, the mTOR signaling cascade also tightly regulates 
autophagy, a cellular survival response that is known to sequester and degrade damaged 
cell organelles, proteins and/or invading pathogens, by regulating the phosphorylation of 
ULK1 at serine 757 (S757) (Khandia et al., 2019; Le Sage et al., 2016; Nazio et al., 2013; 
Schmeisser and Parker, 2019). In the event of nutrient depletion, autophagy is activated 
due to inactivation of mTORC1 and resulting dephosphorylation and activation of ULK1 
(Schmeisser and Parker, 2019) (Fig. 1.6). In the context of virus replication, autophagy 
can be pro-viral or anti-viral. Several viruses including coxsackievirus B3, hepatitis C 
virus, coronaviruses and DENV are known to activate autophagy that enhances viral 
protein synthesis and replication in infected cells (Ke, 2018; Ke and Chen, 2011; Lee et 
al., 2008; Reggiori et al., 2010; Sir et al., 2008; Wong et al., 2008). Furthermore, 
influenza A virus (IAV) has been shown to induce autophagosome formation at early 
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time points of infection and at later time points inhibit the fusion of autophagosomes with 
lysosomes thereby leading to accumulation of autophagosomes in the infected cells 
(Gannage et al., 2009). In contrast, viruses like herpes simplex virus (HSV-1), human 
immunodeficiency virus (HIV), and influenza virus subvert the activation of autophagy to 
enhance their replication (Brand et al., 1997; Lu et al., 1995; Poppers et al., 2000). 
 
1.10 Redox regulation and oxidative stress in virus infection 
1.10.1 Nrf2 signaling cascade 
Nuclear factor E2-related factor 2 (Nrf2) is a modular transcription factor that 
belongs to the cap'n'collar family of transcription factors. It consists of a highly 
conserved leucine-zipper (b-ZIP) structure and seven Neh (Neh 1-7) domains and is 
known to counter oxidative stress (Ramezani et al., 2018; Tonelli et al., 2018). Normally, 
Nrf2 remains associated with Kelch-like erythroid cell-derived protein with CNC 
homology [ECH]-associated protein 1 (Keap1) in the cytoplasm which drives its 
interaction with cullin-3-based E3ubiquitin ligase (Cul3) (Itoh et al., 1999; Kobayashi et 
al., 2004). This association results in poly-ubiquitination of Nrf2, and subsequent 
proteasome mediated degradation resulting in very low basal levels of Nrf2 in cells (Itoh 
et al., 1999; Kobayashi et al., 2004; Taguchi et al., 2011; Tonelli et al., 2018). When a 
cell undergoes oxidative stress, an imbalance in the generation and neutralization of 
reactive oxygen species (ROS) occurs and the association of Keap1 with Nrf2 is impaired 
leading to free Nrf2 which then translocates to the nucleus and induces the expression of 
antioxidant response elements (AREs) (Baird et al., 2014; Itoh et al., 1997; Ramezani et 
al., 2018). AREs are a cluster of multiple genes associated with antioxidant defense, ROS 
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detoxification enzymes, NADPH regeneration and regulation of metabolism that protect 
the cell from the damaging effects of ROS (Baird et al., 2014; Hayes and Dinkova-
Kostova, 2014; Ramezani et al., 2018). The restoration of redox balance is sensed by 
Keap1 which translocates into the nucleus and binds to Nrf2, thereby dissociating Nrf2 
from the AREs. The Keap1/Nrf2 complex translocates back to the cytoplasm where Nrf2 
is poly-ubiquitinated and degraded (Ramezani et al., 2018; Sun et al., 2007). 
 
1.10.2 Nrf2 regulates cellular antioxidant defense system and pentose phosphate 
pathway (PPP) 
Generally, ROS are formed as a byproduct of normal cellular metabolism by 
various cellular enzymes in the mitochondria, endoplasmic reticulum (ER) and 
peroxisomes and are needed to maintain cellular homeostasis and serve as critical 
components of cellular signaling (Arfin et al., 2021; Halliwell, 2007). Cellular 
antioxidant system plays an important role in maintaining a balance between the 
production and scavenging of ROS thereby protecting the cell against damage and 
subsequent death (Dandekar et al., 2015; Pizzino et al., 2017). Oxidative stress is a 
condition in which the generation and scavenging of the ROS is impaired and the balance 
shifts more towards the generation (Sies, 2015; Zhang et al., 2019). Studies done in 
flaviviruses have demonstrated that viruses such as DENV, JEV, and HCV. induce 
glucose uptake, increase expression of key glycolytic and PPP enzymes, enhance lipid 
biosynthesis as well as induce unfolded protein response (UPR) and oxidative stress in 
infected cells (Fontaine et al., 2015; Zhang et al., 2019). The oxidative stress induced by 
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the infection of flaviviruses has been implicated in the virus-induced pathogenesis 
(Valadao et al., 2016).  
DENV infection has been shown to alter intracellular GSH levels, induce 
oxidative stress and cell death in infected cells (Seet et al., 2009; Tian et al., 2010; Wang 
et al., 2013). Recent studies have revealed that in DENV-infected cells, the viral NS2B3 
complex interacts physically with and induces degradation of Nrf2 in a proteolysis-
independent manner, likely through lysosomal degradation/autophagy (Ferrari et al., 
2020; Zevini et al., 2020). Degradation of Nrf2 leads to suppression of antioxidant 
response genes resulting in ROS-associated inflammatory responses and cell death 
(Ferrari et al., 2020; Zevini et al., 2020). Glutathione (GSH) is key player in the 
antioxidant defense system of a cell and Nrf2 is known to control the critical components 
of the GSH antioxidant system (Tonelli et al., 2018). The regulation of GSH levels by 
Nrf2 in a cell is directly controlled by the expression of the glutamate-cysteine ligase 
(GCL) complex that consists of two subunits: the catalytic subunit (GCLC) and the 
modifier subunit (GCLM) (Moinova and Mulcahy, 1999; Wild et al., 1999).  
In addition to regulating the levels of GSH, Nrf2 also regulates the expression of 
enzymes that are key to the conversion of nicotinamide adenine dinucleotide phosphate 
(NADP) to its reduced form NADPH, thereby playing an essential role in maintaining 
cellular redox homeostasis (Gorrini et al., 2013; Tonelli et al., 2018). NADPH is central 
to providing reducing power for the majority of ROS-detoxifying enzymes (Fernandez-
Marcos and Nobrega-Pereira, 2016). Nrf2 induces the production of NADPH by 
positively regulating principal NADPH-generating enzymes glucose-6-phosphate 
dehydrogenase (G6PD), and 6-phosphogluconatedehydrogenase (6PGD), key enzymes 
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involved in the oxidative branch of the pentose phosphate pathway (PPP) as well as other 
enzymes like malic enzyme 1 (ME1) and isocitrate dehydrogenase 1 (IDH1) (DeBlasi 
and DeNicola, 2020; Lee et al., 2003; Mitsuishi et al., 2012; Wu et al., 2011).  The PPP 
branches out from the glycolysis pathway and serves two major functions: i) generation 
of ribose-5-phosphate from glucose-6-phosphate for the synthesis of nucleotides and ii) 
generation of NADPH that is used by the cellular oxidative defense mechanism (Patra 
and Hay, 2014). Both of the above mentioned processes are carried out by the oxidative 
part of PPP (Patra and Hay, 2014). Under oxidative stress condition, the non-oxidative 
part of PPP utilizes transketolase and transaldolase enzymes to convert ribose-5-
phosphate into glucose-6-phosphate that can feed into the oxidative part of PPP to 
generate more NADPH while also being shunted into glycolysis (Patra and Hay, 2014).  
 
1.11 Modulation of cellular metabolism by virus infection 
Virus infection modulates and reprograms cellular metabolism to aid in 
replication and optimal viral progeny production (Thaker et al., 2019a). Metabolic 
changes in virus infected cells closely resemble cancer cells and are characterized by 
increased glycolytic metabolism and anabolic processes to enhance synthesis of 
macromolecules such as nucleotides and lipids (Delgado et al., 2012; Pavlova and 
Thompson, 2016; Thaker et al., 2019a). Several metabolic profiling studies show that 
infection of host cells with viruses such as adenovirus, human cytomegalovirus (hCMV) 
and influenza A virus lead to a significant increase in the rate of glycolysis of the host 
cells (Thaker et al., 2019a). Furthermore, the infection of cells with adenovirus leads to 
increased glutaminolysis, the process in which glutamine is metabolized to glutamate and 
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aspartate resulting in the production of pyruvate, lactate, and citrate (Thai et al., 2015). 
Infection with hCMV has also been reported to increase the translocation of glucose 
transporter, GLUT 4, to the cell surface and increase glucose uptake by the infected cells 
(Yu et al., 2011). Infection with prototypic flaviviruses like DENV and ZIKV have also 
been shown to enhance glycolysis and fatty acid biosynthesis in infected cells (Fontaine 
et al., 2015; Thaker et al., 2019b) 
 
1.12 Overall hypothesis and objectives 
Determining the effect of ZIKV infection on critical host cell signaling pathways 
like the mTOR cascade is essential to achieve a holistic understanding of the molecular 
basis of ZIKV induced pathogenesis. Additionally, a detailed understanding of ZIKV 
induced modulations of host cell pathways can aid in the development of antiviral 
strategies that target the host cell. The association of ZIKV infection with increased 
incidence of microcephaly in neonates together with the findings that both inhibition and 
hyperactivation of the mTOR signaling cascade can lead to defective brain development 
and death of neural progenitor cells led me to hypothesize that ZIKV infection and 
pathogenesis involves the dysregulation of the mTOR signaling pathway. Host 
metabolic adaptations are required for viral replication. We hypothesize that ZIKV virus 
infection hijacks the host cell metabolic machinery for optimal virus propagation, and 
this might lead to increased rate of glucose metabolism and oxidative stress.  These 
hypotheses formed the basis to investigate the role of cellular processes such as the 
mTOR signaling pathway, cell metabolism and antioxidant response in ZIKV replication. 
The following objectives were addressed in this dissertation: 
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1.12.1 Do mTOR signaling cascade and autophagy regulate ZIKV infection? 
The experimental approach and the results of the studies in this objective are 
described in chapter 3. 
1.12.2 How does host antioxidant defense regulate ZIKV replication? 
The experimental approach and the results of the studies in this objective are 
described in chapter 4. 
1.12.3 Does ZIKV infection depend on cellular glycolysis and gluconeogenesis? 
The experimental approach and the results of the studies in this objective are 




CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Cell culture 
The Lund Human Mesencephalic (LUHMES) cells (ATCC CRL-2927), a 
subclone of tetracycline-controlled, v-myc-overexpressing human mesencephalic-derived 
cell line, MESC2.10 (Scholz et al, 2011), obtained from the American Type Culture 
Collection Biosource Center, were cultured as described previously (Scholz et al., 2011). 
Briefly, cell culture flasks and dishes were pre-coated overnight with 50 µg/ml poly-L-
ornithine (Sigma-Aldrich, Cat. # P2533-10G) followed by washing with sterile distilled 
water. Subsequently, they were coated with 1 µg/ml fibronectin (BD Biosciences, Cat. # 
354008), washed with sterile water, air-dried, and stored at 4⁰ C before use. The cells 
were cultured in Dulbecco’s Modified Eagle’s Medium/F12 (DMEM/F12, Hyclone, Cat. 
# SH30023.02), supplemented with Neuroplex N-2 (Gemini, Cat. # 400-163), 2 mM L-
glutamine (Hyclone, Cat. # SH3003401) and 40 ng/ml recombinant basic fibroblast 
growth factor, (Peprotech, Cat. #100-18C). A172 cells (Glioblastoma, Homo sapiens, 
ATCC CRL-1620) were grown in DMEM supplemented with 10% heat inactivated fetal 
bovine serum (FBS) and 1x antibiotics solution (100 U/ml penicillin, 20 U/ml 
streptomycin, PS).  The human neuroblastoma SK-N-SH (Neuroblastoma, Homo sapiens) 
cells stably expressing EGFP-LC3 (Garcia-Garcia et al, 2013) were grown in DMEM 
containing 10% FBS and PS. Vero E6 (Epithelial, Cercopithecus aethiops, ATCC CRL-
1586) cells were grown in DMEM supplemented with 10% FBS and PS. All cells were 




2.2 Preparation and concentration of recombinant ZIKV (rMR) stock 
Stocks of the infectious clone-derived MR766 ZIKV (rMR) were prepared in Vero 
cells as described previously (Annamalai et al, 2017). Briefly, Vero cells were infected 
with rMR virus at a multiplicity of infection (MOI) of 0.1 plaque forming unit per cell 
(PFU/cell). The virus was allowed to adsorp at 37⁰ C for 1 hr following which the 
inoculum was removed and virus growth medium (VGM) [DMEM containing 2%FBS, 
PS, 20 mM hydroxyethyl piperazine ethane sulfonic acid (HEPES), 1 mM sodium 
pyruvate, and non-essential amino acids] was added to the cells. The infected cells were 
incubated at 37⁰ C for 4-5 days until cytopathic effect (CPE) was evident. The culture 
supernatant was collected and clarified at 10,000xg for 30 mins at 4⁰ C. Following 
clarification, the stock virus was stored in small aliquots at -80⁰C. In some experiments 
where higher MOI was used, high titer virus stocks were prepared by ultracentrifugation. 
Briefly, ~10 ml of clarified culture media containing the virus was taken in an 
ultracentrifuge tube and underlaid with ~2 ml of 20% sucrose in PBS. This was followed 
by centrifugation at 100,000xg for 4 h at 4⁰C. The virus pellet was resuspended in 200 µl 
of PBS and stored at -80⁰C. 
 
2.3 Plaque assay 
Plaque assay for virus quantification was done as described in Annamalai et al, 
2017. Briefly, Vero E6 cells were plated in 12 well plate 24 hr prior to the assay. The 
required monolayer confluency was 90-100%. Ten-fold serial dilutions of virus stock or 
culture supernatants for titration were made in cold VGM. One hundred microliters of 
each dilution of the virus were plated in duplicates onto Vero E6 cell monolayers. Cells 
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were incubated at 37°C for 1 h with intermittent rocking every 10 min intervals to 
prevent the cell monolayer from drying and to ensure uniform exposure of the virus 
suspension to the cell monolayer. Following virus adsorption, the inoculum was removed, 
and the cell monolayer was washed once with phosphate buffered saline (PBS) to remove 
any unbound virus. A 1:1 mixture of 2% low gelling temperature (LGT) agarose 
dissolved in sterile distilled water and 2X VGM was added to the cells. The overlay was 
allowed to solidify for 15 min at room temperature and the cells were incubated for 5 
days at 37°C in a humidified cell culture incubator for plaques to develop. Following 
incubation, the cells were fixed with fixing solution containing 10% formaldehyde in 
PBS for at least 60 min. The agarose plugs were removed, and the cell monolayers were 
stained for 30 minutes with staining solution containing 0.1% crystal violet and 30% 
methanol in PBS. The staining solution was removed, and the cells were washed with 
distilled water. The number of plaques was manually counted for each dilution and the 
titer of the virus in the supernatant was determined by multiplying the average number of 
plaques with the dilution factor and was expressed as plaque forming units per ml 
(PFU/ml).  
 
2.4 Antibodies and other reagents 
Anti-phosphorylated (p)-p70S6K (T389)/(p)-p85S6K (T412) (Cat. # 9234S), anti-
p70S6K (Cat. # 2708S), anti-p-Akt (S473) (Cat #. 9018B), anti-Akt (Cat. # 2938P), anti-
mTOR (Cat. # 2983), anti-Rictor (Cat. #2114), anti-Raptor (Cat #2280), and anti-Nrf2 
(Cat #12721T) antibodies were obtained from Cell Signaling Technologies. Anti-p62 
(Cat. # ab109012), anti-G6PD (Cat # ab993), and anti-6PDG (Cat. # 129199) were 
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obtained from Abcam. Anti-ZIKV E antibody was obtained from Genetex (Cat. # 
GTX1333325). Anti-flavivirus group antigen antibody was obtained from Millipore 
(4G2, Cat # MAB10216-I-100UG). Anti-β-actin (Cat. # A2228), goat anti-rabbit 
immunoglobulin (IgG)-horseradish peroxidase (HRP)-conjugated (Cat. # A6154), and 
goat anti-mouse IgG–HRP conjugated (Cat. # A4416) antibodies were obtained from 
Sigma-Aldrich. Choloroquin (CQ) (Cat. # C6628) was obtained from Sigma-Aldrich and 
dissolved in water. 3-Methyladenine (3-MA) was obtained from Tokyo Chemical 
Industry (Cat. # M2518) and was prepared fresh by dissolving in warm water (37-50oC) 
prior to treating cells. Rapamycin was obtained from LC Laboratories (Cat. # R-5000) 
and dissolved in dimethyl sulfoxide (DMSO). Torin1 was obtained from Apex Bio (Cat. 
# A8312-5) and dissolved in ethanol. MRT68921 (Cat. # S7949) were obtained from 
Selleck Chemical and dissolved in water. 6-aminonicotinamide (6-AN) (Cat # 
AAL0669203) was obtained from Thermo Fisher Scientific and dissolved in DMSO. N-
acetyl L-cysteine (NAC) (Cat # AC160280250), Ascorbic acid (Cat # AC352680050), 
and 2-Deoxy-D-glucose (2DG) (Cat # AC111980050) were obtained from Acros 
Organics and dissolved in water. Etomoxir (sodium salt) (Cat # 11969) was obtained 
from Caymen Chemical and dissolved in water. Buthionine sulfoximine (BSO) was 
obtained from Caymen Chemical (Cat # 14484) and dissolved in water. BPTES (Cat # 
19284), UK5099 (UK) (Cat # 16980) and Rotenone (Cat # 13995) were obtained from 




2.5 Immunofluorescence  
For detection of ZIKV E protein in infected cells, cells were mock-infected or 
infected with ZIKV at indicated MOIs. After 24 h, cells were washed with cold 1X PBS 
and fixed with 1:1 mixture of methanol and acetone at -20⁰C for 10 mins. The fixed cells 
were washed with PBS and stained with 4G2 (anti-flavivirus group) antibody (1:1000 in 
PBS). After incubation for 1 h on a shaking platform, excess unbound antibody was 
washed with PBS. The cells were stained with Alexa 488 conjugated anti-mouse IgG 
secondary antibody (1:1000 in PBS) for 1 h. Following washing of unbound antibody 
with PBS, images were acquired using a Nikon Eclipse Ts2R fluorescence microscope.   
 
2.6 Pharmacological inhibition  
For pharmacological inhibition of mTOR kinase, cells were either left untreated 
or were pre-treated with 250 nM torin1 or 1 µM rapamycin for 1 h prior to being mock-
infected or infected with ZIKV at a MOI of 1 with or without the inhibitors and incubated 
in media with or without the inhibitors. Similarly, for inhibition of autophagy, cells were 
either left untreated or treated with 3-MA (5 mM) or MRT68921 (1 µM) for 1 h prior to 
infection with ZIKV with or without the inhibitors and further incubated in media with or 
without the inhibitors till the indicated time points. For the inhibition of autophagic flux, 
cells were treated with CQ (50 µM) 4 h prior to the termination of the experiment. For 
inhibition of de novo synthesis of GSH, cells were incubated with culture medium 
without or with BSO (500 µM) following virus adsorption, for 48 hpi. Similarly, PPP 
inhibition was achieved by treating cells with 6-AN following virus adsorption, for 48 
hpi. For inhibition of glycolysis, following infection with ZIKV, cells were either left 
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untreated or were treated with 2DG (10 mM) for the indicated time points post infection. 
For virus yield under conditions of various drug treatments, 100 µl of culture supernatant 
was collected at the indicated hours post-infection (hpi) and infectious virus titers were 
determined by plaque assay as mentioned above. 
 
2.7 siRNA-mediated protein depletion 
For the depletion of endogenous mTOR, Rictor, Raptor, Nrf2, G6PD and 6PDG 
proteins in A172 cells, we used human small interfering RNA (siRNA) pools targeting 
mTOR (Cat. # J-003008-11 and J-003008-12), Rictor (Cat. # J-016984-05 and J-016984-
06), Raptor (Cat. # J-004107-05 and J-004107-06), Nrf2 (Cat. # L-003755-00-0005), 
G6PD (Cat. # L-008181-02-005) or 6PDG (Cat. # L-008371-00-005) obtained from 
Dharmacon Inc. The siRNAs (obtained at 5 nmol amounts) were reconstituted in 
nuclease-free water. Cells were transfected with siRNAs at a final concentration of 80 
nM for mTOR, Rictor and Raptor or 100 nM for Nrf2, G6PD and 6PDG using 
Lipofectamine RNAiMax (Invitrogen, Cat. # 13778030) following manufacturer’s 
recommendation. Briefly, 80 or 100 nM siRNA and Lipofectamine RNAiMax were 
incubated in OptiMEM medium to facilitate RNA liposome complex formation for 15 
mins at room temperature (RT). A non-targeting (NT) siRNA (Qiagen, Cat. # 1027281) 
at 100 nM was used as negative control. These concentrations of siRNAs were found to 
be nontoxic to the cells and cell viability was estimated to be over 90% during the 
treatment. At 24 hours post siRNA transfection (hpt), the cells were replenished with 
DMEM containing 2% FBS and 1X antibiotics and were incubated for further 24-48 h 
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prior to virus infection. The extent of protein depletion was determined by western 
blotting as mentioned below using corresponding antibodies. 
 
2.8 Preparation of cell lysates, SDS-PAGE and Western blotting 
For western blotting, cell monolayers were washed once with cold PBS, detached 
with trypsin (Gibco Cat #25200056) and collected in microcentrifuge tubes. This was 
followed by centrifugation at 500xg for 5 min at 4oC. The cell pellet was resuspended in 
RIPA lysis buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1 % Triton X-100, 1 % 
sodium deoxycholate, 0.1 % SDS) supplemented with the Halt Protease and Phosphatase 
inhibitor cocktail (ThermoFisher, Cat. # 1861281) and incubated on ice for 5 min and 
frozen at -80⁰ C for 1 hr. This was followed by thawing the cells on ice and sonicating at 
10% amplitude for 5-10 secs, 3 times. The cell lysates were clarified by centrifugation at 
10,000xg for 5 min and total protein quantification was done using the bicinchoninic acid 
(BCA) assay kit (Pierce, Cat. # 23225). Twenty five µg of total protein was separated by 
electrophoresis on 6 % or 8 % polyacrylamide gel containing sodium dodecylsulphate 
(SDS-PAGE). The separated proteins were transferred onto polyvinylidene difluoride 
(PVDF) membranes (ThermoFisher, Cat # 88520) using a Bio-Rad semi-dry transfer 
system. Non-specific protein binding was blocked with 5% non-fat milk or with bovine 
serum albumin (for phosphorylated proteins) in Tris-buffered saline containing 0.2 % 
tween-20 (TBS-T) for 1 hr followed by incubation with the appropriate primary 
antibodies (dilution: 1:5000 for β-actin and 1:1000 for all others) at 4°C overnight. 
Membranes were washed three times with TBS-T and followed by incubation with goat 
anti-rabbit or goat anti-mouse HRP-conjugated secondary antibodies (dilution: 1:5000) at 
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room temperature (RT) for 2 h. The blots were washed three times with TBS-T and bands 
were detected using ECL western blotting substrate (Pierce, Cat. # 32106) in a BioRad 
imager. Protein bands were analyzed by ImageJ software (NIH). 
 
2.9 Fluorescence activated cell sorting  
A172 cells were seeded in 12-well plates at a density of 20,000 cells per well. 
They were left untreated or treated with pharmacological inhibitors, mock-infected or 
infected with ZIKV and incubated for 96 hrs. Culture media were collected and the cell 
monolayers were washed with PBS, detached with trypsin, resuspended with collected 
medium, and pelleted at 500xg for 10 mins. The cell pellet was re-suspended in staining 
solution containing propidium iodide (PI, 1 µg/ml, Sigma/Aldrich, Cat # P4170) for 
detecting loss of plasma membrane integrity and, monochlorobimane (mBCl, 10 μM, 
Molecular Probes, Cat # M1381MP) in PBS to determine intracellular glutathione (GSH) 
content and incubated at room temperature (RT) until analysis. Cell viability was 
determined by flow cytometry (Fluorescence Activated Cell Sorting, FACS) using Cytek-
DxP-10 (BD Biosciences). PI was detected using BluYel FL-3 (488 nm excitation, 
695/40 nm emission) and mBCl was detected using VioFL1 (389 nm excitation and 483 
nm emission) channels. At least 10,000 events were recorded per sample. Viable cells 
were gated as mBCl positive (+) and PI negative (−). The data analysis was done in 




2.10 Confocal microscopy 
SK-N-SH cells stably expressing EGFP-LC3 (Garcia-Garcia et al., 2013) were 
seeded in 35mm glass bottom cell culture dishes at a density of 200,000 cells per dish. 
After 24 hrs of seeding, the cells were mock-infected or infected with ZIKV at an MOI of 
1 and incubated for 48 hrs. Four hours prior to the termination of the experiment, the cells 
were exposed to CQ (50 M). To visualize lysosomes, cells were incubated with 1 µM 
LysoTracker Red DND-99 (Invitrogen, Cat. # L7528) for 10 min, the monolayer was 
washed once with PBS and immediately imaged as described (Garcia-Garcia et al., 
2013). Fluorescent imaging was done at the microscopy core facility of University of 
Nebraska-Lincoln using a Nikon A1R-Ti2 confocal system. Images were acquired using 
NIS-Elements software (Nikon). EGFP-LC3 puncta in cells were counted from three 
representative fields of images and were analyzed statistically.  
 
2.11 Statistical analysis 
Experimental replicas were independent and performed on separate days. The 
data were analyzed by using one-way or two-way ANOVA, and the appropriate post-hoc 
test using Graphpad Prism package. When ANOVA assumptions were not met (normality 
[Shapiro–Wilk test] or equal variance [Kruskal-Wallis]), one-way ANOVA on Ranks or 
data transformation (two-way ANOVA) were performed on the data collected. Data were 





CHAPTER 3: mTOR SIGNALING ACTIVATION ANTAGONIZES 
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ZIKV is a flavivirus and is transmitted by mosquitoes of the Aedes species. While 
most infections do not produce any clinical symptoms, the recent outbreak in Brazil has 
been linked to microcephaly and other neurological defects in neonates and Guillain-
Barré syndrome in adults. The molecular mechanisms regulating ZIKV infection, and the 
pathogenic outcomes associated with it are not completely understood. Signaling by the 
mechanistic (mammalian) target of rapamycin (mTOR) kinase is important for cell 
survival and proliferation. Several previous studies across multiple virus families have 
demonstrated that virus infections hijack this critical cellular signaling cascade for their 
replication.  In this study, we show that in human neuronal precursor cells and glial cells 
in culture, ZIKV infection activates both mTOR complex 1 (mTORC1) and mTORC2. 
When mTOR kinase was inhibited either by Torin1 or rapamycin, significant reduction in 
ZIKV protein expression and progeny production was observed. Depletion of the 
defining subunit of mTORC1, Raptor, in glial cells by small interfering RNA (siRNA) 
resulted in inhibition of ZIKV protein expression and viral replication. The depletion of 
Rictor, the unique subunit of mTORC2, or the mTOR kinase in the cells also inhibited 
the viral processes, albeit to a lesser extent. ZIKV infection in glial cells was seen to 
transiently induce autophagy at early time point post-infection. It was seen that when 
autophagosome elongation is impaired by the class III phosphatidylinositol 3-kinase 
(PI3K) inhibitor 3-methyladenine (3-MA), viral protein accumulation and progeny 
production was enhanced. Furthermore, the phosphorylation at S757 and the resulting 
inactivation of ULK1 by mTOR at later stages of ZIKV infection suggests a link between 
autophagy inhibition and mTOR activation by ZIKV. Accordingly, inhibition of ULK1 
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(by MRT68921) or autophagy (by 3-MA) reversed the effects of mTOR inhibition, 
leading to increased levels of ZIKV protein expression and viral progeny production. 
These results demonstrate that ZIKV replication requires the activation of both mTORC1 
and mTORC2, which negatively regulates autophagy and facilitates the viral replication. 
Additionally, these findings provide a potential mechanism of the neurological diseases 
induced by ZIKV infection. 
  
3.2. Introduction 
Recent studies suggest that ZIKV infection leads to defective neuronal cell 
development and death of neuronal precursor cells and that such events might lead to the 
development of neurological complications (Faizan et al., 2016). The mTOR signaling 
cascade is a key pathway that regulates cellular growth, proliferation, and survival 
(Saxton and Sabatini, 2017b). mTOR is a serine/threonine kinase that belongs to the 
phosphatidylinositol 3-kinase (PI3K)-related protein kinase family and constitutes the 
catalytic subunit of two functionally distinct complexes, mTOR complex 1 (mTORC1) 
and mTORC2 (Saxton and Sabatini, 2017b). The regulatory associated protein of mTOR 
(Raptor) and the rapamycin-insensitive companion of mTOR (Rictor) are essential and 
distinguishing subunits of mTORC1 and mTORC2, respectively (Saxton and Sabatini, 
2017b) and act as scaffold proteins to help assemble and stabilize the respective 
complexes (Yang et al., 2013). Phosphorylation and subsequent activation of downstream 
effectors of mTORC1, such as the p70 ribosomal S6 kinase 1 (p70S6K), the eukaryotic 
initiation factor 4E (eIF4E)-binding protein 1 (4EBP1), and Unc-51-like autophagy 
activating kinase 1 (ULK1), regulate cap-dependent mRNA translation, metabolism, and 
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protein/ organelle quality control mechanisms (Saxton and Sabatini, 2017b). mTORC2 is 
reported to phosphorylate several proteins of the AGC family of kinases, such as protein 
kinase C (PKC), protein kinase B (PKB/Akt), and the serum and glucocorticoid induced 
kinases (SGK) and this regulates various aspects of cytoskeletal structure modeling and 
cellular survival (Saxton and Sabatini, 2017b).  
mTOR signaling is one of the critical pathways that is essential for proper brain 
development and is also known to regulate autophagy (Ganley et al., 2009). Virus 
infection is known to alter the mTOR complex activity (Buchkovich et al., 2008; Jan et 
al., 2016; Le Sage et al., 2016). While poxviruses disrupt mTORCs’ regulatory cascade 
(Meade et al., 2018), adenoviruses are known to activate mTORC1 (de Groot et al., 1995; 
O'Shea et al., 2005). The NS1 protein of influenza A virus activates mTOR signaling 
network by phosphorylating and activating Akt, a key protein in the mTOR signaling 
pathway, and by inhibiting REDD1 (regulated in development and DNA damage 
responses 1), a key inhibitor of mTORC1 (Kuss-Duerkop et al., 2017). Flaviviruses such 
as west Nile virus (WNV) and dengue virus (DENV) have been reported to activate 
PI3K/Akt and mTORC signaling (Lee et al., 2005; Shives et al., 2014) that results in 
increased viral protein expression and replication (Shives et al., 2014). The NS4A and 
NS4B proteins of ZIKV have been shown to inhibit Akt-mTOR signaling in human fetal 
neuronal stem cells (Liang et al., 2016).  
Autophagy is a cellular homeostatic process involving the formation of 
autophagosomes, which engulf protein aggregates, damaged cell organelles, and 
intracellular pathogens marked for degradation (Deretic et al., 2013) and is known to play 
a major role in eliciting a host response against virus infections (Lee and Iwasaki, 2008). 
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Pathogens like herpes simplex virus 1 (HSV-1) (Poppers et al., 2000)(29), human 
immunodeficiency virus (HIV) (Brand et al., 1997), and influenza virus (Lu et al., 1995) 
are known to inhibit the activation of autophagy to enhance virus replication. While 
induction of autophagy facilitates DENV replication (Chu et al., 2014), it restricts WNV 
replication and protein synthesis and acts as an antiviral response of the host cell 
(Kobayashi et al., 2014). In contrast, ZIKV infection has been shown to induce 
autophagy human fetal neural stem cells and this inhibits neurogenesis (Liang et al., 
2016). Since mTOR and autophagy are key signaling cascades that regulate many cellular 
processes, exploring how ZIKV perturbs these pathways is important to gain better 
insights into the processes of ZIKV infection, and pathogenesis. 
In this chapter, we demonstrate that ZIKV infection results in the activation of 
both mTORC1 and mTORC2 in neuronal and glial cells. Inhibition of mTOR kinase 
reduces ZIKV protein expression and progeny virus production. Additionally, these 
studies reveal that ZIKV infection induces autophagy at early stages of infection but that 
later in infection, autophagy is subdued by the concerted activation of both mTORC1 and 
mTORC2 that leads to viral protein accumulation in the infected cells and virus growth. 
These results demonstrate that activation of mTOR signaling, and the subsequent 
suppression of autophagy are events that are required for ZIKV growth in vitro and 
provide a framework for further research on the role of these two cellular pathways for 
understanding of the mechanism(s) underlying ZIKV induced pathogenesis. 
 
3.3. Results 




Virus infections are known to modulate mTOR signaling (Buchkovich et al., 2008; 
Jan et al., 2016; Le Sage et al., 2016). In order to investigate the effect of ZIKV infection 
on mTOR signaling in neuronal cells, we used neuronal progenitor LUHMES cells 
(Scholz et al., 2011) and examined the status of mTORC1 activation in these cells 
infected with ZIKV by determining the levels of phosphorylation (p) of eukaryotic 
translation initiation factor 4E binding protein (4E-BP1), a downstream substrate of 
mTORC1 (Saxton and Sabatini, 2017b). 4E-BP1 is phosphorylated at multiple sites 
resulting in its inhibition and dissociation from eIF4E which leads to cap-dependent 
protein translation in cells (Gingras et al., 1999; Gingras et al., 1998). Using an antibody 
that detects the phosphorylation of 4E-BP1 at residues Thr37 and Thr46 (residues 
phosphorylated by mTORC1), we observed that upon ZIKV infection, there was an 
increase in the levels of phosphorylated protein with time, clearly indicating the 
activation of mTORC1 (Fig. 3.1A). Additionally, we also sought to determine the levels 
of p-p70S6K, another downstream substrate of mTORC1 (Saxton and Sabatini, 2017b; 
Yang et al., 2013). Western blot analysis showed that the levels of p-p70S6K at threonine 
389 (T389) increased following ZIKV infection (Fig. 3.1B). In the LUHMES cells, the 
phospho-specific antibody used also detected a second phosphorylated isoform of the 
protein, p-p85S6K (T412), which is derived from the same gene and contains 23 extra 
amino acids at the amino terminus (Pullen and Thomas, 1997). The increase in 
phosphorylation of both the downstream substrates of mTORC1 was evident at 12 to 24 h 






Figure 3.1: ZIKV infection activates both mTORC1 and mTORC2 in neuronal and 
glial cells in culture. LUHMES cells were either mock-infected (M) or infected with 
ZIKV at an MOI of 1 and cells lysates were prepared at the indicated hours post-infection 
(hpi). The lysates were subjected to Western blot analysis to detect A p-4E-BP1 and β-
actin, B  p-p70S6K (T389), total p70S6K, ZIKV E protein, and β-actin using the 
corresponding antibodies. The phospho-specific antibody against p70S6K also detected a 
slower migrating p-p85S6K (T412) band (1B; top panel). C A172 cells were mock-
infected (M) or infected with ZIKV at an MOI of 1 and cells lysates were prepared at the 
indicated hpi. The lysates were subjected to Western blot analysis to detect p-p70S6K 
(T389), total p70S6K, pAkt (S473), total Akt, ZIKV E protein, and β-actin using the 
corresponding antibodies. The ratios p-p70S6K/p70S6K, p-Akt/Akt, and ZIKV E/β-actin 
from these images are shown in italics. The p-p70S6K/p70S6K and p-Akt/Akt ratios in 
mock-infected cells and ZIKV E/β-actin ratio in ZIKV-infected culture at 48 hpi were set 
at 1. Relative electrophoretic mobility of molecular mass markers in kD is shown on the 
right. nd, not determined.  
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cells (Fig. 3.1A-B). Detectable levels of ZIKV envelope (E) protein were observed at 24 
hpi, suggesting that viral protein expression occurred in parallel to the activation of the 
mTOR signaling cascade (Fig. 3.1B). To determine if mTORC1 activation by ZIKV 
infection occurs in a cell type-independent manner or is restricted to the neuronal 
precursor cells, we examined the levels of p-p70S6K (T389) in A172 (human 
glioblastoma) cells infected with ZIKV. Results show that the levels of p-p70S6K (T389) 
were higher in ZIKV-infected A172 cells (Fig. 3.1C) than in mock-infected cells, 
suggesting that mTORC1 activation by ZIKV infection is independent of the type of cells 
used.  
Since mTORC1 was found to be activated by ZIKV infection, we next examined 
if mTORC2 was also activated by the virus infection. mTORC2 has distinct substrates 
and physiological effects (Saxton and Sabatini, 2017b). Activated mTORC2 
phosphorylates the downstream kinase Akt/PKB at serine 473 (S473); therefore, we 
examined the levels of p-Akt (S473) in A172 cells infected with ZIKV. The results 
showed a progressive increase in the levels of p-Akt (S473) with time compared to the 
mock-infected cells (Fig. 3.1C), suggesting that activation of mTORC2 also occurs in 
ZIKV-infected cells. Thus, the results clearly show for the first time that ZIKV infection 
activates both mTORC1 and mTORC2 in different cell types, including neuronal and 
glial cells in culture, and that this effect is paralleled with ZIKV protein expression. 
 
3.3.2. ZIKV replication is dependent on mTORC1 and mTORC2 activity. 
Enhanced mTOR cascade activity has been shown to be associated with both 
increased and decreased viral replication (Le Sage et al., 2016). Since the previous results 
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suggested that ZIKV infection activates mTOR, we next investigated whether activation 
of mTORCs is required for ZIKV replication. To this end, we used Torin1 that is known 
to inhibit mTOR kinase activity, potently and selectively, by an ATP-competitive 
mechanism (Thoreen et al., 2009; Zask et al., 2009). To examine the effect of mTOR 
kinase inhibition on ZIKV replication, cells were pretreated with or without Torin1 for 1 
h followed by infection with ZIKV. The cells were then incubated in the presence of 
Torin1 for 48 h. Western blot analysis of infected cell lysates showed that while the 
levels of p-p70S6K (T389) were considerably higher in ZIKV-infected cells than in 
mock-infected cells, the presence of Torin1 led to nearly undetectable levels of p-p70S6K 
(T389) in the virus-infected cells (Fig. 3.2A). Likewise, the levels of p-Akt (S473), which 
were higher in ZIKV-infected cells, were undetectable in the presence of Torin1 (Fig. 
3.2A). Importantly, ZIKV E protein expression was greatly reduced in the presence of 
Torin1 (Fig. 3.2A).  
Examination of infectious virus yield from the infected cell culture supernatants 
revealed significantly lower virus titers in cells treated with Torin1 at 48 hpi and 72 hpi 
than in untreated cells (Fig. 3.2B). These results clearly demonstrated that mTOR kinase 
activity is essential for viral protein expression and progeny production. Although the 
virus growth at 24 hpi and 96 hpi was less in the presence of Torin1 than in its absence, 
the inhibitory effect was not significant. The observed lack of significant inhibitory effect 
of Torin1 at these time points could be due to the fact that ZIKV growth is not substantial 
at 24 hpi, as has been seen previously (Annamalai et al., 2017), or to a decrease in the 
viability of cells at 96 hpi because of virus-induced cell death. Indeed, viability of ZIKV-




Figure 3.2: ZIKV replication requires both mTORC1 and mTORC2 activity. A 
A172 cells were either left untreated (-) or pre-treated (+) with torin1 for 1 h prior to 
being mock-infected or infected with ZIKV at an MOI of 1 in the continued presence of 
torin1. Cell lysates were prepared at 48 hpi and subjected to Western blot analyses to 
detect p-p70S6K (T389), total p70S6K, pAkt (S473), total Akt, ZIKV E protein, and β-
actin using the corresponding antibodies. The ratios p-p70S6K/p70S6K, p-Akt/Akt, and 
ZIKV E/β-actin from these images are shown in italics. The p-p70S6K/p70S6K and p-
Akt/Akt ratios in mock-infected, torin1-untreated cells and ZIKV E/β-actin ratio in 
ZIKV-infected, torin1-untreated culture were arbitrarily set at 1. Relative electrophoretic 
mobility of molecular mass markers in kD is shown on the right. nd, not determined. B 
Cell culture supernatants from untreated (vehicle) or torin1-treated and ZIKV-infected 
cells were collected every 24 hpi for quantitation of virus yield by plaque assay. C Cell 
viability was evaluated by flow cytometry in mock-infected (mock) and ZIKV-infected 
(ZIKV) cells at 96 hpi in the presence or absence (vehicle) of torin1. Error bars represent 





ZIKV-induced cell death (Fig. 3.2C). These results clearly revealed an essential role for 
mTOR activity in viral protein expression, infectious-progeny production, and ZIKV-
induced cell death. 
To determine if ZIKV replication is dependent on either mTORC1, mTORC2, or 
both, we used rapamycin. Rapamycin has been reported to complex with FK506-binding 
protein (FKBP), a nonobligate component of mTORC1. The FKBP-rapamycin complex 
interacts with mTOR kinase and is known to inhibit its activity (Dumont and Su, 1996; 
Feldman et al., 2009). A172 cells were pretreated with rapamycin for 1 h, infected with 
ZIKV, and subsequently incubated in the presence of rapamycin for 48 h. We observed 
that ZIKV-induced p-p70S6K (T389) was considerably reduced in the presence of 
rapamycin (Fig. 3.3A, lane 4) along with reduction in the levels of the viral E protein. 
While rapamycin is known to primarily inhibit mTORC1, resulting in inhibition of 
p70S6K (T389) phosphorylation, it can also suppress the assembly and function of 
mTORC2 upon extended exposure, leading to the inhibition of Akt phosphorylation at 
S473 as well (Sarbassov et al., 2006). Accordingly, the levels of p-Akt (S473) were also 
reduced in the presence rapamycin (Fig. 3.3A, lane 4), indicating that mTORC2 activity 
induced by ZIKV infection is also inhibited by rapamycin. Similar to what was observed 
in the presence of Torin1, culture supernatants showed significantly reduced virus titers 
from infected cell culture supernatants treated with rapamycin at 48 hpi and 72 hpi (Fig. 
3.3B). Again, the reduced virus yield and observed lack of significant difference in 
infectious virus titers at 96 hpi was due to increased virus-induced cell death at 96 hpi, 
which was prevented by rapamycin (Fig. 3.3C). Overall, these results demonstrated that 




Figure 3.3: ZIKV replication requires both mTORC1 and mTORC2 activity. A 
A172 cells were either left untreated (-) or pre-treated (+) with rapamycin for 1 h prior to 
being mock-infected or infected with ZIKV at an MOI of 1 in the continued presence of 
rapamycin. Cell lysates were prepared at 48 hpi and subjected to Western blot analyses to 
detect p-p70S6K (T389), total p70S6K, pAkt (S473), total Akt, ZIKV E protein, and β-
actin using the corresponding antibodies. The ratios p-p70S6K/p70S6K, p-Akt/Akt, and 
ZIKV E/β-actin from these images are shown in italics. The p-p70S6K/p70S6K and p-
Akt/Akt ratios in mock-infected, rapamycin-untreated cells and ZIKV E/β-actin ratio in 
ZIKV-infected, rapamycin-untreated culture were arbitrarily set at 1. Relative 
electrophoretic mobility of molecular mass markers in kD is shown on the right. nd, not 
determined. B Cell culture supernatants from untreated (vehicle) or rapamycin-treated 
and ZIKV-infected cells were collected every 24 hpi for quantitation of virus yield by 
plaque assay. C Cell viability was evaluated by flow cytometry in mock-infected (mock) 
and ZIKV-infected (ZIKV) cells at 96 hpi in the presence or absence (vehicle) of 





However, the pharmacological inhibition of mTOR signaling was inconclusive with 
regard to whether activation of either mTORC1 or mTORC2 is required for virus 
replication. 
 
3.3.3. Both mTORC1 and mTORC2 are required for ZIKV replication. 
To unequivocally examine the role of mTOR in ZIKV replication, we conducted 
experiments in which critical protein components of the mTORC1, mTORC2, or both 
were depleted. Since the mTOR kinase is the central component of both complexes, 
whereas Raptor and Rictor are the unique scaffolding subunits of mTORC1 and 
mTORC2, respectively, we used specific small interfering RNAs (siRNAs) against the 
proteins to   deplete the cells of these proteins and examine the effects on ZIKV E protein 
expression and progeny production. In cells transfected with siRNA targeting mTOR 
kinase, the levels of mTOR protein were greatly reduced compared to that seen with non-
targeting (NT) siRNA (Fig. 3.4A, lanes 3 and 4). Similarly, when siRNAs targeting 
Raptor (Fig. 3.4A, lanes 7 and 8) or Rictor (lanes 5 and 6) were used, depletion of the 
corresponding proteins was also observed. Importantly, the reduction in these protein 
levels was associated with downregulation of phosphorylation of the corresponding 
substrates: p70S6K for mTORC1 (Raptor) (Fig. 3.4B, lanes 7 and 8) and Akt for 
mTORC2 (Rictor) (Fig. 3.4B, lanes 5 and 6). These results corroborate that siRNA-
mediated depletion of Raptor or Rictor leads to significant downregulation of the 
activities of mTORC1 or mTORC2.  
In cells infected with ZIKV, a dramatic reduction in the levels of E protein was 





Figure 3.4: siRNA mediated depletion of mTOR complex 1 (mTORC1) and 2 
(mTORC2) components. A A172 cells were transfected with either non-targeting (NT) 
siRNA or siRNAs targeting mTOR kinase (mTOR), Rictor or Raptor for 72 h and mock-
infected (M) or infected with ZIKV for 48 h. Cell lysates were prepared and subjected to 
Western blot analyses to detect mTOR, Raptor, Rictor, and β-actin using the 
corresponding antibodies. The ratios mTOR/β-actin, Rictor/β-actin, and Raptor/β-actin, 
from these images are shown in italics. The ratios for mTOR/β-actin, Rictor/β-actin, and 
Raptor/β-actin from uninfected and NT siRNA-treated cells were set at 1. Relative 
electrophoretic mobility of molecular mass markers in kD is shown on the right. B Cell 
lysates from the same experiment were subjected for Western blot analysis to detect p-
p70S6K (T389), total p70S6K, pAkt (S473), total Akt, and β-actin using the 
corresponding antibodies. The ratios p-p70S6K/p70S6K and p-Akt/Akt, from these 




Figure 3.5: mTOR complex 1 (mTORC1) and 2 (mTORC2) regulate ZIKV 
replication. A A172 cells were transfected with either non-targeting (NT) siRNA or 
siRNAs targeting mTOR kinase (mTOR), Rictor or Raptor for 72 h and mock-infected 
(M) or infected with ZIKV for 48 h. Cell lysates were prepared and subjected to Western 
blot analyses to detect ZIKV E and β-actin using the corresponding antibodies. The ratios 
ZIKV E/β-actin from these images are shown in italics. The ratio for ZIKV/β-actin, from 
infected and NT siRNA-treated cells were set at 1. Relative electrophoretic mobility of 
molecular mass markers in kD is shown on the right. B Infectious virus production in 
cells depleted of mTOR, Rictor, or Raptor. The experiments were conducted as described 
in panel A, culture supernatants from infected cells were collected at various hpi and 
assayed for infectious virus yield by plaque assay. Horizontal discontinuous line 
represents limit of detection. #, virus titer is below the limit of detection. Error bars 





consistent with the results in Fig. 3.2 and 3.3 obtained with the use of Torin1 and 
rapamycin, respectively. When Raptor (Fig. 3.5A, lane 8) or Rictor (lane 6) was depleted 
from the cells through the use of the corresponding siRNAs, the levels of the viral E 
protein in these infected cells were also dramatically reduced. These results suggest that 
both mTORC1 and mTORC2 are necessary for optimal levels of viral protein expression. 
It is interesting to note that while the depletion of Raptor led to nearly undetectable levels 
of E protein expression (Fig. 3.5A, lane 8), the depletion of Rictor led to detectable but 
significantly reduced (lane 6) levels of the viral E protein expression. These results show 
that the requirement for mTORC1 in viral E protein expression is more important than 
the requirement for mTORC2. However, the role of mTORC2 as a critical regulator of 
ZIKV replication cannot be ignored. 
 Consistent with drastic reduction in viral E protein expression, we also observed 
significant reduction in infectious progeny production in cells with depleted mTOR 
kinase, Raptor, or Rictor (Fig. 3.5B). Although depletion of mTOR kinase or Rictor led 
to levels of production of infectious progeny that were significantly lower than those in 
cells treated with NT siRNA, the effect of Raptor depletion was most dramatic in that 
infectious virus production was below the level of detection at 24, 48, or 72 hpi, whereas 
at 96 hpi, the virus titers were significantly lower than those from NT siRNA-treated cells 
(Fig. 3.5B). Thus, these results show that both mTORC1 and mTORC2 are required for 
ZIKV protein expression and infectious virus production; however, mTORC1 appears to 




3.3.4. ZIKV infection induces autophagy, which suppresses the virus replication. 
As mTOR signaling is known to regulate autophagy (Ganley et al., 2009), a 
cellular homeostatic pathway that can also function as an antiviral response to virus 
infection (Lee and Iwasaki, 2008), we investigated the role of autophagy in ZIKV 
infection. Flaviviruses, including ZIKV, infection is known to activate autophagy (Ke, 
2018; Liang et al., 2016). Microtubule-associated protein 1A/1B-light chain 3 (LC3) is a 
soluble protein that is recruited to autophagosomal membranes and is commonly used as 
a marker for changes in autophagosome dynamics. Therefore, we examined the 
distribution of LC3 in cells infected with ZIKV at various times points post infection.  
Human neuroblastoma SK-N-SH cells stably expressing LC3 labeled with enhanced 
green fluorescent protein (EGFP-LC3) (Garcia-Garcia et al., 2013) were mock infected or 
infected with ZIKV (Fig. 3.6A). Following incubation for indicated lengths of time, the 
cells were either untreated or treated with chloroquine (CQ) 4 h prior to the termination 
of the experiment to avoid any unintended negative effects of CQ on ZIKV infection and 
block autophagosome cargo degradation (Delvecchio et al., 2016). The cells were 
subsequently stained with LysoTracker Red (a marker for lysosomes) and examined by 
fluorescence microscopy. Results showed that ZIKV infection significantly increased the 
accumulation of EGFP-LC3 punctum clusters at 12 and 24 hpi compared to mock 
infected cells in the presence or absence of CQ, an inhibitor of lysosomal cargo 
degradation (Fig. 3.6A-B). These results suggest that ZIKV infection increases autophagy 
flux at early time points of infection. 
To corroborate these observations, we evaluated changes in the levels of lipidated 




Figure 3.6: Autophagy is induced in cells infected with ZIKV. A SK-N-SH cells 
stably expressing EGFP-LC3 were mock-infected or infected with ZIKV at an MOI of 1. 
The cells were left untreated or treated with CQ for 4 h prior to the termination of the 
experiment followed by staining with LysoTracker Red before being examined by 
fluorescence microscopy. Arrowheads in merged images indicate EGFP-LC3 puncta 
clusters. Arrows indicate enlarged cells with higher abundance of EGFP-LC3 clusters. 
Scale bar: 10 µm. B Quantification of EGFP-LC3 puncta per cell (n ≥ 37) from three 
representative fields is shown. Error bars represent ± SEM. One-Way ANOVA on Ranks; 






presence of ubiquitinated substrates (Lamark et al., 2017). A172 cells infected with ZIKV 
showed an early increase in the levels of p62 monomers as well as aggregates at 12 and 
24 hpi in comparison to mock infected cells (Fig. 3.7A). Interestingly, the p62 levels 
decreased over time, and by 48 hpi, they were comparable to those in mock-infected cells 
(Fig. 3.7A). The levels of p62 aggregates were also similar to that of monomeric p62 at 
the indicated times post ZIKV infection. Similarly, an increase in LC3-II level was 
observed between 12 and 24 hpi, which decreased at later time points (Fig. 3.7A). These 
results clearly show that ZIKV infection results in activation of autophagy at early times 
after infection and is suppressed as infection proceeds. In the presence of CQ, the levels 
of p62 and LC3-II increased slightly further in the infected cells at 12 hpi (Fig. 3.7B, lane 
6) in comparison to mock-infected cells (lane 2) and tapered off at later times post 
infection. These results corroborate that ZIKV infection induces an increase in autophagy 
flux at early times (12 to 24 h) following infection. To assess the effect of autophagy 
induction on viral protein expression, we examined the levels of viral E protein 
expression in cells infected with ZIKV in the presence or absence of 3-methyladenine (3-
MA), a purine analog known to block autophagosome elongation by inhibiting the class 
III PI3K signaling cascade (Petiot et al., 2000; Seglen and Gordon, 1982). Inhibiting 
autophagy by 3-MA resulted in the accumulation of p62 that was paralleled by a decrease 
in the levels of lipidated LC3-II in infected and mock-infected cells (Fig. 3.8A). 
Importantly, we observed that there was an increase in the accumulation of viral E 
protein in infected cells treated with 3-MA compared to cells not treated with 3-MA (Fig. 
3.8A), which suggests that autophagy prompts the degradation of viral treated with 3-MA 





Figure 3.7: ZIKV induced autophagy. A A172 cells were either mock-infected (M) or 
infected with ZIKV at an MOI of 1. Cell lysates were prepared at various hpi, subjected 
to Western blot analysis to detect levels of p62 and LC3-II using corresponding 
antibodies. Monomeric p62 levels are presented on top panel. A longer exposure of the 
same blot showing the p62 monomer as well as the p62 aggregates towards the top of the  
blot is shown in the panel below that. Ratios of p62 monomer/β-actin, p62 aggregates/β-
actin, and LC3-II/β-actin are shown in italics with the ratios in mock-infected culture set 
arbitrarily at 1. Relative electrophoretic mobility of molecular mass markers in kD is 
shown on the right. B A172 cells were either mock-infected (M) or infected with ZIKV at 
an MOI of 1. CQ was added 4 h prior to harvesting cell lysates at the indicated time 
points. Levels of p62, LC3-II, and β-actin were analyzed by Western blotting. 
Representative image from three independent experiments is shown. Ratios of p62/β- 
actin, and LC3-II/β-actin are shown in italics with the ratios in mock-infected culture set 




Figure 3.8: ZIKV-induced autophagy suppresses virus replication. A A172 cells were 
mock-infected (M) or infected with ZIKV at an MOI 1 in the presence (+) or absence (-) 
of 3-MA, cell lysates were prepared at the indicated time points and the levels of p62, 
LC3-II, viral E protein, and β-actin were examined by Western blot analysis. Ratios of 
p62/β-actin, LC3-II/β-actin and ZIKV E/β-actin are shown in italics with the ratios set 
arbitrarily at 1 as shown. B Infectious progeny virus titers as determined by plaque assay 
from ZIKV-infected cells untreated (Vehicle) or treated with 3-MA. Error bars represent 





induction of autophagy upon ZIKV infection (12 to 24 hpi) is indeed a cellular defense 
mechanism that suppresses viral protein accumulation and progeny production, but at 
later stages in ZIKV infection (  24 hpi), autophagy is suppressed to allow ZIKV protein 
accumulation and progeny production. 
 
3.3.5. mTOR activation suppresses autophagy and allows ZIKV replication. 
I next wanted to investigate if the role of mTOR in the regulation of viral protein 
expression and progeny production is linked to autophagy. mTORC1 has been shown to 
phosphorylate ULK1 at serine 757 (S757) to negatively regulate autophagy (Kim et al., 
2011). To this end, we examined cell lysates of ZIKV-infected cells harvested at different 
times following infection for the expression of p-ULK1 (S757). The results showed an 
increase in the levels of p-ULK1 (S757) with time after the virus infection (Fig. 3.9A) 
that parallels the gradual decline in the levels of p62 and LC3-II (Fig. 3.7A), suggesting 
that ZIKV-induced phosphorylation of ULK1 suppresses autophagy. Accordingly, 
inhibition of mTORC1 by Torin1 ablated ULK1 phosphorylation (Fig. 3.9B) with a 
concomitant increase in autophagy, as evidenced by the enhanced degradation of p62 and 
LC3-II (Fig. 3.9B). As shown before, the level of ZIKV E protein was reduced 
substantially in the presence of Torin1 (Fig. 3.9B). These results suggest that during 
ZIKV infection, phosphorylation, and the subsequent inhibition of ULK1 by mTOR 
inhibit autophagy and facilitate ZIKV E protein accumulation.  
Since inhibiting mTOR kinase resulted in increased autophagy with a concomitant 
decrease in viral E protein levels, we wanted to investigate if inhibiting autophagy with 










Figure 3.9: ZIKV infection induces ULK1 phosphorylation and suppresses 
autophagy.  A Phosphorylation of ULK1 is enhanced in ZIKV-infected cells. A172 cells 
were either mock-infected (M) or infected with ZIKV at an MOI of 1. Cell lysates were 
prepared at various hpi and subjected to Western blot analysis for p-ULK (S757), total 
ULK1 and β-actin. Ratio of p-ULK1/ULK1 is shown in italics with the ratio in mock-
infected culture set arbitrarily at 1 B Inhibition of mTORC1 by torin1 leads to reduced 
ULK1 phosphorylation and reduced detection of the viral E protein.  A172 cells treated 
with (+) or without (-) torin1 were mock-infected (M) or infected with ZIKV. Cell 
extracts were prepared at 49 hpi and the levels of p-ULK1 (S757), total ULK, p62, LC3-
II, ZIKV E protein, and β-actin were examined by Western blotting. Ratios of p-
ULK1/ULK1, p62/β-actin, LC3-II/β-actin and ZIKV E/β-actin are shown in italics with 
the ratios set arbitrarily at 1 as shown.  
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mTOR kinase activity has already been impaired would result in rescue of viral E protein 
levels and infectious-progeny production. Data from such an experiment would provide 
unequivocal evidence for a direct link between mTOR activation, suppression of 
autophagy, and viral replication. The enhanced autophagy induced by Torin1, as 
evidenced by the increased degradation of p62 and LC3-II, was reversed by 3-MA (Fig. 
3.10A, compare lanes 3 and 4 with lanes 9 and 10) or MRT68921 (Fig. 3.10A, compare 
lanes 3 and 4 with lanes 11 and 12) in cells infected with ZIKV or left uninfected. 
However, only in cells infected with ZIKV did 3-MA and MRT68921 prevent the 
decrease in E protein levels induced by Torin1 (Fig. 3.10A, compare lane 4 with 10 and 
lane 4 with 12). Furthermore, infectious virus production, which is also inhibited 
significantly in the presence of Torin1, was seen to be rescued to the untreated-control 
levels in the presence of 3-MA or MRT68921 (Fig. 3.10B). Overall, these observations 
clearly show that activation of mTOR in ZIKV infected cells suppresses autophagy to 
allow virus protein expression and progeny production. 
 
3.4. Discussion 
Studies have demonstrated that ZIKV infection hinders growth and development 
of neurospheres and organoid cultures in vitro (Garcez et al., 2016; Garcez et al., 2017; 
Qian et al., 2017). It has also been demonstrated that ZIKV infection causes abnormal  
neurological development and fetal demise in mice (Lazear and Diamond, 2016; Li et al., 
2016a; Miner et al., 2016). Yet, the molecular mechanisms of ZIKV induced 




Figure 3.10: Inhibition of autophagy under condition of mTORC inhibition rescues 
ZIKV replication. A and B Inhibiting autophagy under condition of mTORC inhibition 
rescues viral E protein accumulation A and progeny production B. A172 cells were either 
mock-infected (-) or infected with ZIKV (+) and treated without (-) or with (+) various 
inhibitors as shown on top of each lane in panel A. Cell extracts were prepared at 48 hpi 





p62/β-actin, LC3-II/β-actin, and ZIKV E/β-actin are shown in italics with the ratios set 
arbitrarily at 1 as shown.  Under similar experimental conditions, culture supernatants 
from the infected cells at 72 hpi were assayed for infectious progeny production B by 




regulates many cellular processes such as growth, survival, and proliferation (Saxton and 
Sabatini, 2017a).  
Many viruses are known to either activate or suppress mTORC signaling to 
facilitate viral replication (Le Sage et al., 2016). Additionally, prototypic flaviviruses 
such as the WNV, DENV, Japanese encephalitis virus (JEV) and hepatitis C virus (HCV)  
are known to activate the Akt/mTOR pathway and this activation may be proviral or an 
antiviral role in nature (Le Sage et al., 2016). While inhibition of mTOR activates 
autophagy and enhances DENV replication (Jan et al., 2016), mTORC1 supports WNV 
replication (Shives et al., 2014). With regard to HCV, the role of mTOR appears to be 
controversial in that some studies suggest a proviral role of mTOR activation (Peng et al., 
2010; Stohr et al., 2016) while others advocate for an antiviral role (Johri et al., 2019; 
Shao et al., 2010; Shrivastava et al., 2012). Additionally, activation of mTOR and 
mTOR-dependent mechanisms have been implicated in the enzootic transmission cycle 
of some flaviviruses involving the mosquito vector (Hansen et al., 2004). Therefore, 
modulation of mTOR signaling appears to be integral to flavivirus transmission, 
replication, and pathogenesis.  
Using human neuronal progenitor (LUHMES) and glioblastoma (A172) cells, we 
observed activation of mTORC1 following infection with ZIKV. Further studies revealed 
that ZIKV infection activated not only mTORC1 but also mTORC2 to facilitate viral 
protein expression, accumulation, and progeny virus production. These studies also 
revealed that early during ZIKV infection, autophagy is activated that results in the 
restriction of viral protein accumulation to undetectable levels but at later times, 




Figure 3.11: Scheme of ZIKV-induced regulation of autophagy, mTOR signaling, 
and effects on viral protein accumulation, progeny virus production and cell death 
in infected cells. (A) ZIKV infection induces an early activation of autophagy (≤ 24 hpi) 
that mediates the degradation of viral proteins preventing viral assembly. (B) Later stages 
of infection (≥ 24 hpi) activate mTORC1 and mTORC2 to mediate the phosphorylation 
and inhibition of ULK1, whose activity is necessary for autophagy initiation. Inhibition 
of autophagy facilitates accumulation of viral proteins, infectious progeny release, and 
cell death. The timeframe of the events delineated here is likely dependent on the cell 
type for infection, the exposure time and dosage of the virus.  
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mTORC1. This leads to increased levels of viral protein accumulation in the infected 
cells and enhanced viral progeny production. 
ZIKV infection induces autophagy (Cao et al., 2017; Cugola et al., 2016; Hamel 
et al., 2015) but there are conflicting results as to the effect of autophagy on ZIKV 
infection. Some studies report that inhibition of autophagy reduces viral replication and 
limits viral transmission (Abernathy et al., 2019; Cao et al., 2017; Hamel et al., 2015). 
ZIKV-induced autophagy was also shown to be mediated by inhibition of the Akt-mTOR 
pathway by the viral NS4A and NS4B proteins, leading to defective neurogenesis (Liang 
et al., 2016). In contrast, other studies have reported that autophagy facilitates virus 
clearance in phagocytes (Huang et al., 2020) and protects cells against ZIKV infection 
(Karuppan et al., 2020; Liu et al., 2018). On the other hand, pharmacological and genetic 
inhibition of autophagy was shown to have no adverse effect on ZIKV replication in glial 
cells (Ojha et al., 2019).  
While the conflicting findings in regard to the role of autophagy and mTOR in 
ZIKV infection could be attributed to the different cell types and experimental model 
systems that these cellular events were tested in, it could also be linked to the temporality 
of the events being analyzed. In addition, the experimental tools used to study mTOR 
signaling might be a point of discrepancy. While phosphorylation of mTOR at S2448 has 
been used in many studies as a marker for mTOR activation, there is clear evidence that 
pS2448 does not correlate with mTOR activity (Figueiredo et al., 2017). Using different 
cell types, we demonstrated that mTORC1 and mTORC2 are consistently activated by 
evaluating the phosphorylation status of their direct substrates, p70S6K, ULK1 
(mTORC1) and Akt (mTORC2), which are considered as more reliable readouts of 
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mTOR activation (Saxton and Sabatini, 2017a). We have clearly defined that while 
autophagy is initiated early during the infection process, it is later on suppressed by 
ZIKV-induced mTOR activation. Very few studies have addressed the time-course of 
changes in such events and thus point to the importance of these results.  
The role of the individual complexes in ZIKV protein expression and progeny 
production could not be ascertained using torin1 or rapamycin due to the lack of 
specificity of these compounds. By using siRNAs to deplete the critical components of 
the two complexes, we was able to firmly conclude that both mTORC1 and mTORC2 are 
required for efficient ZIKV replication, although a differential effect was noted in their 
requirements. mTORC1 appears to play a more dominant role in ZIKV replication 
compared to mTORC2. This is borne out from the observations that Raptor depletion led 
to extremely low to undetectable levels of viral protein expression and infectious progeny 
production (Fig. 3.5), while Rictor depletion led to significantly reduced but still 
detectable levels of E protein expression and progeny production.  
Several studies have provided evidence for a major role for mTORC1 in virus 
replicative processes, but the role for mTORC2 has been less clear. Replication of WNV, 
HCV, influenza virus, Andes virus and herpesviruses require mTORC1 but not mTORC2 
(Clippinger et al., 2011; Kuss-Duerkop et al., 2017; McNulty et al., 2013; Moorman and 
Shenk, 2010; Shives et al., 2014; Stohr et al., 2016). Only one previous study showed that 
Rictor (mTORC2) is primarily involved in HCMV replication (Kudchodkar et al., 2006). 
Although the NS5A protein of HCV activates mTORC2 (George et al., 2012), no 
experimental evidence links this activation to viral replication. Therefore, one important 
finding from my studies reported here is the significant involvement of mTORC2 in 
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replication of ZIKV. The mTORC2 may play an indirect role, likely upstream of 
mTORC1 activation through phosphorylation of Akt, an activator of mTORC1 
(Sarbassov et al., 2005). Since a negative feedback loop between mTORC1 activation 
and mTORC2 has been described where p70S6K phosphorylates Rictor and decreases 
mTORC2 function (Efeyan and Sabatini, 2010; Julien et al., 2010), it is possible that 
ZIKV also overcomes this negative feedback loop to facilitate the potentiation of 
mTORC1 activation by mTORC2. 
 It is interesting to note that depletion of mTOR kinase itself resulted in still 
detectable levels of E protein expression and progeny production, while knockdown of 
Raptor exerted a more robust negative effect. Knockdown of Rictor induced a more 
pronounced decrease in Akt phosphorylation than mTOR downregulation (Fig. 3.4). 
Since mTOR kinase is central to both mTORC1 and mTORC2, our expectation was that 
depletion of mTOR would have the most significant negative impact on viral E protein 
expression and progeny production as well as on the corresponding downstream 
substrates compared to the Raptor or Rictor depletion. A direct comparison between the 
knockdown of mTOR, Rictor, and Raptor cannot be made by just comparing the changes 
in protein levels or the phosphorylation of the corresponding substrates as this would 
require that the antibodies used for detection had similar signal-to-noise ratio efficiencies. 
However, a possibility exists that Raptor might partially regulate ZIKV replication 
independent from mTOR. Indeed, a recent study reports mTOR-independent functions 
for Raptor (Kim et al., 2016). Similarly, Rictor has been shown to form mTOR-less 
complexes that mediate different processes including Akt phosphorylation (Gkountakos 
et al., 2018; McDonald et al., 2008). To address an mTOR-independent role of Raptor 
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and Rictor in ZIKV infection is an interesting area of research that requires further 
experimentation. 
The inability to detect viral proteins in ZIKV-infected cells prior to 24 hpi was 
surprising given that the viral genome is a competent template for translation 
immediately after entry into cells. We considered the possibility that autophagy was 
being activated early in ZIKV infected cells resulting in inhibition of viral protein 
accumulation to undetectable levels. Flaviviruses are known to activate autophagy, which 
plays an important role in replication and/or pathogenesis (Ke, 2018). For example, the 
viral NS4A-induced autophagy protects DENV- and Modoc virus (a murine flavivirus)-
infected cells and enhances virus replication (McLean et al., 2011) whereas ZIKV NS4A- 
and NS4B-induced autophagy inhibits neurogenesis (Liang et al., 2016). Autophagy is 
also induced in DENV- and HCV-infected cells to support viral replication (Chu et al., 
2014; Dreux et al., 2009) while in a separate study, autophagy was found to play no role 
in WNV infection (Beatman et al., 2012).  
Our results (Fig. 3.7) show that autophagy was indeed induced early (within 24 
hpi) in ZIKV-infected cells and thereafter there was a gradual decline in the autophagy 
flux. The decline in autophagy flux was concomitant with increase in mTOR activation as 
seen by increased phosphorylation of ULK1. In addition to p-ULK1, mTORC1 activation 
has been shown to inhibit autophagy at other signaling steps, so we cannot rule out other 
targets that mediate the negative regulation of autophagy by ZIKV-induced mTORC1 
activation (Kim and Guan, 2015). Based on the findings reported here, we propose that 
activation of autophagy is an early antiviral response against ZIKV infection (Fig. 3.11A) 
that is then suppressed by the virus-induced activation of mTORC signaling, leading to 
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enhanced viral protein accumulation and progeny production (Fig. 3.11B). However, it is 
important to recognize that the temporality of these events might change depending on 
the cell types or experimental model systems used and the conditions of infection 
including virus dose and length of infection. While inhibition of autophagy increased 
viral protein accumulation, it only occurred at 24 hpi, which also suggests the existence 
of other unexplored mechanisms by which the cell limits viral replication at early time 
points of infection. 
The mechanisms involved in autophagy activation by ZIKV are incompletely 
understood. Although NS4A and NS4B proteins have been shown to induce autophagy 
through inhibition of mTOR signaling (Liang et al., 2016), we have observed that the 
induction of autophagy precedes viral protein accumulation with no evidence of 
inhibition of mTOR signaling. A recent report demonstrated that ZIKV induces an NF-
κB-dependent autophagy pathway mediated by STING (Liu et al., 2018). Another report 
demonstrates that in astrocytes activation of NF-κB and autophagy by ZIKV infection 
seems to depend on TL3 receptors (Ojha et al., 2019). Thus, autophagy could be triggered 
by the induction of antiviral innate immune responses prior to viral replication. It is also 
possible that adenosine-monophosphate (AMP)-activated kinase (AMPK), which is 
activated by ZIKV (Thaker et al., 2019a) could induce autophagy. It is unknown at this 
time what viral factors drive activation of autophagy early in infection and mTORC 
signaling. However, we have observed that autophagy is not activated when UV-
inactivated ZIKV is used in the experiments, suggesting that live virus infection is 
necessary. Which antiviral immune responses and viral structural and/or non-structural 
proteins are involved in the activation of autophagy and the later induction of mTOR 
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signaling are not known at this time and remains to be investigated. Bystander effects 
from infected cells could also contribute to the modulation of autophagy. Indeed, 
previous reports have demonstrated that the release of soluble factors including cytokines 
can regulate autophagy in non-infected cells (Kong et al., 2018; Van Grol et al., 2010; 
Wu et al., 2016). 
Since hyperactive mTOR signaling is linked to exhaustion of stem cell niches and 
loss of mTOR activity leads to depletion of progenitor cells responsible for the normal 
development of the brain (Takei and Nawa, 2014), these results might also point to 
potential mechanism(s) of ZIKV-induced neurological deficits in developing fetal brains. 
Further exploration in this aspect can provide a better understanding into the molecular 




CHAPTER 4: REDOX REGULATION OF ZIKA VIRUS REPLICATION 
 
4.1. Abstract 
ZIKV is a mosquito-transmitted flavivirus and its association with microcephaly, 
other congenital abnormalities in the developing fetus and Guillain-Barré syndrome, 
neuropathy, and myelitis in adults and older children is a major concern to public health. 
The molecular machinery regulating ZIKV infection are still unclear. While it is well 
known that viral infections alter host cell redox homeostasis that can either be pro-viral or 
anti-viral in nature, exact mechanisms and consequences for different viruses are not 
clearly understood. The results show that ZIKV infection induces oxidative stress in 
neuronal and glial cells in culture which transiently activates the nuclear factor erythroid 
2 p45-related transcription factor 2 (Nrf2) signaling cascade. We demonstrate that 
downregulation of Nrf2 or inhibition of de novo GSH synthesis was shown to increase 
viral protein synthesis and infectious particle production. Additionally, depletion of the 
enzymes, glucose 6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate 
dehydrogenase (6PGD), critical contributors to the generation of NADPH increased viral 
replication. Although pharmacologic inhibition of G6PD and 6PGD by 6-amino 
nicotinamide (6-AN) resulted in significant inhibition of viral protein synthesis and 
infectious progeny production, the inhibition could not be rescued by D-ribose, indicating 
that pentose phosphate pathway (PPP) does not appear to play a major role in viral 
replication. These results highlight the importance of cellular redox homeostasis in the 





Several studies have shown that prototypic flaviviruses including HCV, DENV as 
well as JEV induce oxidative stress upon infection and which correlates with disease 
pathogenesis (Gil et al., 2004; Korenaga et al., 2005; Liao et al., 2002; Zhang et al., 
2019). Upon infection, the virus hijacks host cell metabolism which triggers stress on the 
cell. Generally, cellular metabolism leads to the generation of reactive oxygen species 
(ROS) such as superoxide anion (O2•−), singlet oxygen (1O2) and hydrogen peroxide 
(H2O2) in mitochondria, ER, and peroxisomes. These ROSs at moderate levels can serve 
as critical cofactors in cellular signaling and are promptly neutralized by antioxidant 
defense system (Birben et al., 2012). But in an infected cell, the redox homeostasis is 
altered by virus induced metabolic changes and resulting in the induction of oxidative 
stress (Zhang et al., 2019).  
Increased oxidative stress can have a multitude of consequences including lipid 
peroxidation, protein carbonyl formation, DNA damage and activates multiple stress 
induced transcription factors that further downregulate antioxidant response and amplify 
oxidant induced cellular damage (Birben et al., 2012; Cooke et al., 2003; Dalton et al., 
1999). It has been shown that the induction of oxidative stress can be beneficial to viral 
replication in host cells. Flaviviruses are known to control 5’ RNA genome capping by 
inducing oxidative stress in infected cells (Gullberg et al., 2015). Dengue virus (DENV) 
is known to induce oxidant-triggered autophagy in infected cells leading to inhibition of 
apoptotic cell death and increased viral replication (Datan et al., 2016). Additionally, 
DENV infection has been reported to reduce cellular GSH pool, which generally 
downregulates ROS and maintains redox homeostasis and pharmacological inhibition of 
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GSH synthesis enhanced viral replication (Tian et al., 2010). HCV causes chronic 
hepatitis in infected patients by triggering oxidative stress and downregulating 
antioxidant response (Ivanov et al., 2013; Rebbani and Tsukiyama-Kohara, 2016; Vasallo 
and Gastaminza, 2015). 
The nuclear factor erythroid 2–related transcription factor 2 (Nrf2) signaling 
cascade is a key player in the cellular antioxidant system (Hayes and Dinkova-Kostova, 
2014). When the redox homeostasis is maintained, Nrf2 stably associates with kelch-like 
ECH- associated protein 1 (Keap1) and is constitutively ubiquitinated and degraded via 
the ubiquitin- proteasome pathway (Cullinan et al., 2004; Hayes and Dinkova-Kostova, 
2014). Upon oxidative stress induction, stable association of Nrf2 and Keap1 is altered by 
conformational changes in Keap1 leading to its dissociation and resultant activation of 
Nrf2 (Cullinan et al., 2004; Hayes and Dinkova-Kostova, 2014). Subsequently, the 
heterodimerization of Nrf2 with small Maf (sMaf) proteins leads to nuclear translocation 
of Nrf2 where it induces the activation of antioxidant response elements (AREs), a cluster 
of genes involved in antioxidant response, cellular protection, and regulation of 
autophagy (Hayes and Dinkova-Kostova, 2014; Pajares et al., 2016; Pajares et al., 2018). 
Additionally, Nrf2 is involved in the de novo synthesis of GSH, an important intracellular 
antioxidant, by directly modulating the activity of Glutamate-Cysteine Ligase Catalytic 
subunit (GCLC), and reduced Nicotinamide adenine dinucleotide phosphate (NADPH), 
by inducing the activity of the enzymes G6PD and 6PGD (Hayes and Dinkova-Kostova, 
2014). 
Although few studies have implicated the induction of oxidative stress in ZIKV 
infected cells, a detailed understanding of the molecular mechanisms involved therein is 
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poorly understood. In this study, we demonstrate that ZIKV infection of neuronal and 
glial cells in culture results in the induction of oxidative stress that triggers transient 
activation of Nrf2 signaling cascade. The activation of Nrf2 is found to be antagonistic to 
ZIKV replication since its depletion promotes ZIKV protein synthesis and infectious 
virion production. Furthermore, transient activation of Nrf2 in ZIKV infected cells leads 
to the activation of its downstream effectors, GCLC and G6PD which are known to be 
involved in the synthesis of glutathione (GSH) and generation of NADPH, critical 
contributors to the cell’s antioxidant system. Both, inhibition of de novo GSH synthesis 
by BSO or depletion of NADPH generating enzymes, G6PD or 6PGD, resulted in 
enhanced ZIKV replication. These results highlight the antiviral role played cellular 
antioxidant response in ZIKV infection. 
 
4.3. Results 
4.3.1. ZIKV infection induces oxidative stress in neuronal and glial cells in culture 
ZIKV has been reported to have a wide cellular tropism (Lazear and Diamomd, 
JVI review in 2016?) and is known to infect cells of neuronal origin. Using the neuronal 
progenitor LUHMES cells, we first sought to determine the susceptibility of these cells to 
ZIKV infection as it had not been reported previously. Immunofluorescence imaging for 
ZIKV E protein shows that LUHMES are permissive to infection by ZIKV, and this is 
dependent on the multiplicity of infection (MOI) (Fig. 4.1A). Western blot analysis 
revealed that the expression of ZIKV E protein in LUHMES cells was also MOI- 




Figure 4.1: ZIKV infection induces oxidative stress in LUHMES cells. A Cells were 
either mock-infected (M) or infected with ZIKV at the indicated MOI and at 24 hpi, the 
cells were fixed and stained with anti-flavivirus E antibody followed by Alexa 488 
conjugated secondary antibody. Fluorescence images show cells infected with ZIKV 
(green) at indicated MOIs. B Cells were either mock-infected (M) or infected with ZIKV 
at the indicated MOI and at 24 hpi, lysates were prepared and subjected to Western blot 
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analysis to detect ZIKV E protein and β-actin using the corresponding antibodies. 
Relative electrophoretic mobility of molecular mass markers in kilo Daltons (kD) is 
shown on the right. Flowcytometry analysis show the MOI dependent induction of 
mitochondrial C and cytosolic D oxidative stress measured using MitoSox and 
Dihydroethidium (DHE) respectively in mock-infected vs ZIKV-infected cells . (E) 
Flowcytometry analysis show the MOI dependent reduction on Glutathione content in 




Additionally, ZIKV infection triggered an MOI dependent increase in ROS, both 
mitochondrial (Fig. 4.1C) and cytosolic (Fig. 4.1D), which was paralleled with the 
reduction of cellular GSH content (Fig. 4.1E). Similarly, infection of A172 human 
glioblastoma cells led to expression of viral E protein which was detectable at 24 hpi with 
a maximal expression between 48 and 72 hpi (Fig. 4.2A). The virus infection also led to 
an increase in the accumulation of mitochondrial ROS that is evident at 48 hpi (Fig. 4.2B 
and C) and increased significantly by 72 hpi. A parallel significant reduction in cellular 
GSH content was also evident at 72 hpi in infected cells (Fig. 4.2D and E). These results 
unequivocally demonstrate that ZIKV infection induces oxidative stress in neuronal 
precursor and glial cells. 
 
4.3.2. Nrf2 activation precedes oxidative stress and antagonizes viral replication 
 Previous studies have demonstrated that ZIKV induces oxidative stress (Almeida 
et al., 2020; Ledur et al., 2020; Li et al., 2017a; Simanjuntak et al., 2018), but conflicting 
results exist in regards to the activation of the antioxidant response by Nrf2 (Almeida et 
al., 2020). Nrf2 is a functionally active transcription factor constitutively expressed in the 
cell. However, under normal conditions of cell growth, it is negatively regulated by its 
ubiquitination and degradation via the proteasome. Nrf2 degradation is interrupted upon 
oxidative stress to become stabilized and transcriptionally active (Nguyen et al., 2009). In 
contrast to ROS formation, ZIKV induced an early stabilization of Nrf2 at 12 hpi that 
peaked between 24-48 hpi (Fig. 4.3). In mock-infected cells, Nrf2 was undetectable (Fig. 
4.3, lane 1). This is likely attributed to the observation that under normal conditions Nrf2 




Figure 4.2: ZIKV infection induces oxidative stress in A172 cells. A Cells were either 
mock-infected (M) or infected with ZIKV at MOI 1 and at the indicated hpi, lysates were 
prepared and subjected to Western blot analysis to detect ZIKV E protein and β-actin 
using corresponding antibodies. Relative electrophoretic mobility of molecular mass 
markers in kD is shown on the right. B Flowcytometry analysis show time-dependent 
induction of mitochondrial oxidative stress C and D measured using MitoSox and GSH 




Figure 4.3: Nrf2 activation precedes oxidative stress and antagonizes ZIKV 
replication. Cells were either mock-infected (M) or infected with ZIKV at MOI 1 and at 
the indicated hpi, lysates were prepared and subjected to Western blot analysis to detect 
Nrf2, GCLC, G6PD, ZIKV E and β-actin using corresponding antibodies. Relative 
electrophoretic mobility of molecular mass markers in kD is shown on the right.  
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(Stewart et al., 2003; Tonelli et al., 2018). Subsequent downregulation of Nrf2 at 72 hpi 
coincided with the increase in ROS accumulation in A172 cells (Fig. 4.2B and C).  
Activation of Nrf2 resulted in concomitant increase in the protein levels of the glutamate 
cysteine ligase (GCLC, catalytic subunit) and glucose 6-phosphate (P) dehydrogenase 
(G6PD) (Fig. 4.3), whose gene transcription is driven by AREs recognized by Nrf2. The 
temporality of increased expression of both GCLC and G6PD was coincident with the 
stabilization of Nrf2. Describe data on viral E protein! 
 While pharmacological activation of Nrf2 has been previously shown to inhibit 
ZIKV genome replication (Huang et al., 2017), the effect of Nrf2 depletion in ZIKV 
replication has not been determined. siRNA mediated depletion significantly reduced the 
levels of Nrf2 in ZIKV infected cells (Fig. 4.4A, lanes 3 and 4). The inability of detecting 
Nrf2 in mock-infected cells transfected with siNT or siNrf2 (Fig. 4.4A, lanes 1 and 2)  is 
consistent with our previous observation (Fig. 4.3). The depletion of Nrf2 also resulted in 
reduced expression of both GCLC and G6PD in ZIKV infected cells that were transfected 
with siNrf2 in comparison to cells transfected with siNT (Fig. 4.4A, lanes 3 and 4). Nrf2 
knockdown increased ZIKV protein expression (Fig. 4.4A). At least a two- to three-fold 
increase in E protein expression at 48 hpi was observed in multiple repeat experiments. 
Interestingly, infectious virus particle release was significantly increased from cells 
depleted of Nrf2 as compared to cells treated with siNT (Fig. 4.4B). The increase in virus 
yield ranged from nearly 200-fold at 72 hpi to about 20-fold at 96 hpi with nearly 40-fold 
and 70-fold increase at 24 hpi and 48 hpi, respectively (Fig. 4.4B). It should be noted that 
the reduced fold-increase in virus titer at 96 hpi is likely due to ZIKV-induced cell death 
that we have observed in previous experiments.  Furthermore, downregulation of Nrf2 
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Figure 4.4: siRNA mediated depletion of Nrf2 enhances ZIKV replication. A Cells 
were transfected with either non-targeting (NT) siRNA (siNT) or siRNAs targeting Nrf2 
(siNrf2) and mock-infected (M) or infected with ZIKV at MOI 1 and at 48 hpi, lysates 
were prepared and subjected to Western blot analysis to detect Nrf2, GCLC, G6PD, 
ZIKV E and β-actin using corresponding antibodies. Relative electrophoretic mobility of 
molecular mass markers in kD is shown on the right. B Cell culture supernatants from NT 
or siNrf2 transfected and ZIKV-infected cells were collected at the indicated times for 
quantitation of virus yield by plaque assay. C Cell viability was evaluated by flow 
cytometry in siNT or siNrf2 transfected, mock-infected (mock) or ZIKV-infected (ZIKV) 
cells at 96 hpi. Error bars represent ± SEM. *, p ≤0.1; **, p ≤0.01; ***, p ≤0.001.   
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increased cell death induced by ZIKV (Fig. 4.4C). These results demonstrate that Nrf2 
activation counters ZIKV replication and its depletion leads to enhanced replication of 
the virus. 
 
4.3.3. Glutathione reduces ZIKV replication and cell death  
 I next decided to evaluate the role of the antioxidant response triggered by Nrf2 
on ZIKV replication. The Nrf-2-dependent increase in GCLC observed upon ZIKV 
infection (Fig. 4.4A) suggested a role of glutathione (GSH) synthesis in viral infection, as 
GCLC mediates the rate-limiting step in de novo GSH formation by  the synthesis of its 
precursor, γ-glutamylcysteine (Franco and Cidlowski, 2012). Since I had observed that 
ZIKV infection induced GSH depletion (Fig. 4.1E, 4.2D and E) that paralleled the 
downregulation of Nrf2/GCLC at 72 hpiobserved after its initial peak between 24-48 hpi 
(Fig. 4.3), we examined the effect of buthionine sulfoximine (BSO), an irreversible 
inhibitor of GCLC (Franco and Cidlowski, 2012) on ZIKV replication. In the presence of 
BSO, ZIKV protein expression was increased approximately 2- to 3-fold (Fig. 4.5A) 
while infectious virus yield  in the supernatants was significantly enhanced (Fig. 4.5B). 
Again, the increase in virus yield ranged from nearly 120-fold at 72 hpi to about 20-fold 
at 96 hpi with nearly 80-fold and 85-fold increase at 24 hpi and 48 hpi, respectively, as 
compared to BSO-untreated cells. These results  correlate well with the results obtained 
when Nrf2 is downregulated (Figs. 4.4A and B). Similarly, ZIKV-induced cell death was 
also enhanced (Fig. 4.5C). These results demonstrate an antiviral role of Nrf2 via GSH 





Figure 4.5: Glutathione reduces ZIKV replication and cell death . A Cells were 
mock-infected (M) or infected with ZIKV at MOI 1 followed by treatment with vehicle (-
) or BSO (+)  and at 48 hpi, lysates were prepared and subjected to Western blot analysis 
to detect ZIKV E and β-actin using corresponding antibodies. Relative electrophoretic 
mobility of molecular mass markers in kD is shown on the right. B Cell culture 
supernatants from vehicle (ND) or BSO treated, and ZIKV-infected cells were collected 
at the indicated times for quantitation of virus yield by plaque assay. C Cell viability was 
evaluated by flow cytometry in Vehicle or BSO treated mock-infected (Mock) or ZIKV-
infected (ZIKV) cells at 96 hpi. Error bars represent ± SEM. *, p ≤0.1; **, p ≤0.01; ***, 
p ≤0.001.  
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4.3.4. ZIKV replication is augmented by NADPH depletion 
 Similar to GCLC, G6PD was transiently upregulated in an Nrf2-dependent 
manner during ZIKV replication (Fig. 4.3). G6PD and 6-phosphogluconate 
dehydrogenase (6PGD) are NADP-dependent oxidoreductases within the pentose 
phosphate pathway (PPP) that regenerate nicotinamide adenine dinucleotide phosphate 
(NADPH) whose reductive power fuels numerous antioxidant/reductive systems 
(Stanton, 2012). The antioxidant function of GSH is primarily mediated by the activity of 
GSH peroxidases (GPx), which catalyze the reduction of peroxides (hydrogen peroxide 
[H2O2], peroxynitrite [ONOO
-] or lipid peroxides [LOOH]). The resultant GSH disulfide 
or oxidized GSH (GSSG) is reduced by GSH reductase (GR) using NADPH as cofactor 
(Fig. 4.9) (Franco and Cidlowski, 2012). Because GSH synthesis exerted an inhibitory 
effect on ZIKV replication, it was expected that G6PD and 6PGD would also be 
inhibitory. In line with this assumption, we found that the depletion of G6PD and 6PGD 
enhanced viral protein and infectious virion production (Fig. 4.6A and B). In contrast, 
pharmacological inhibition of G6PD and 6PGD by 6-AN significantly inhibited viral 
replication (Fig. 4.7A and C). The inhibitory effect 6-AN was not cell specific as it was 
also observed in VeroE6 (African green monkey kidney epithelial cells) cells (Fig. 4.7B). 
6-AN also inhibited ZIKV-induced cell death (Fig. 4.7D). In addition to its role in 
replenishing NADPH pool, the PPP generates ribose 5P, a precursor for the synthesis of 
nucleotides. We next explored the possibility that supplementing cells with D-Ribose 
under the condition of pharmacologic inhibition of G6PD and 6PGD by 6-AN would 




Figure 4.6: siRNA mediated depletion of G6PD and 6PGD. A A172 cells were transfected 
with either non-targeting (siNT) siRNA or siRNAs targeting G6PD or 6PGD for 48 h and 
subsequently mock-infected (M) or infected with ZIKV for 48 h. Cell lysates were prepared and 
subjected to Western blot analyses to detect G6PD, 6PGD, ZIKV E and β-actin using the 
corresponding antibodies. Relative electrophoretic mobility of molecular mass markers in kD is 
shown on the right. B Infectious virus production in cells depleted of G6PD or 6PGD in 
comparison to siNT transfected cells. The experiments were conducted as described in panel A, 
culture supernatants from infected cells were collected at the indicated hpi and assayed for 
infectious virus yield by plaque assay. Horizontal discontinuous line represents limit of detection. 





Figure 4.7: 6-AN inhibits ZIKV replication. A A172 B VeroE6 cells were mock-
infected (M) or infected with ZIKV at MOI 1 followed by treatment with vehicle (-) or 6-
AN (+)  and at 48 hpi, lysates were prepared and subjected to Western blot analysis to 
detect ZIKV E and β-actin using corresponding antibodies. Relative electrophoretic 
mobility of molecular mass markers in kD is shown on the right. C Cell culture 
supernatants from vehicle (-) or 6-AN (+) treated, and ZIKV-infected cells were collected 
at indicated times for quantitation of virus yield by plaque assay. D Cell viability was 
evaluated by flow cytometry in vehicle or 6-AN treated and (+) mock-infected (Mock) or 
ZIKV-infected (ZIKV) cells at 96 hpi. Error bars represent ± SEM. Ns, non significant; 
**, p ≤0.01; ****, p ≤0.0001.   
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AN still inhibited ZIKV replication and no rescue of ZIKV protein levels was observed 
(Fig. 4.8). Considering the contrasting results obtained by siRNA mediated depletion and 
pharmacological inhibition of PPP enzymes, G6PD and 6PGD, it is possible that the 
inhibitory effect of 6-AN on ZIKV replication is independent of the PPP and is likely by 
hitherto unknown mechanism. 
 
4.4 Discussion 
The recent outbreak of ZIKV in the Americas revealed serious neurological and 
developmental pathologies in fetuses and adults. The interplay between ZIKV infection 
and the resultant induction of oxidative stress in infected cells can contribute to serious 
outcomes such congenital defects and developmental abnormalities. Yet a clear 
understanding of the molecular mechanisms involved is still absent. This study focused 
on the effect of ZIKV infection on the redox homeostasis in neuronal and glial cells. 
ZIKV infection of human neuronal progenitor LUHMES cells revealed that these 
cells are permissive to virus infection and that ZIKV infection resulted in a significant 
increase in the accumulation of ROS. Additionally, a marked reduction of the GSH 
content was observed. The presence of higher amounts of reduced GSH in a cell is 
indicative of good overall cellular health and a balanced redox state. ZIKV infection 
resulted in a significant decrease in the cellular GSH pool indicating oxidative stress 
induction and resulting damage. Similarly, infection of human glioblastoma A172 cells 
showed accumulation of ROS and a marked decrease in GSH levels signifying oxidative 
damage.  




Figure 4.8: Inhibition of ZIKV E expression by 6-ASN is not rescued by D-Ribose. 
A172 cells were mock-infected (M) or infected with ZIKV at MOI 1 followed by 
treatment with vehicle (-) or 6-AN (+)  in the absence (-) or presence (+) of D-Ribose and 
at 48 hpi, lysates were prepared and subjected to Western blot analysis to detect ZIKV E 
and β-actin using corresponding antibodies. Relative electrophoretic mobility of 





Figure 4.9: ZIKV induces oxidative stress and activates Nrf2/antioxidant pathway. 
ZIKV infection and protein synthesis in infected cells generate oxidative stress that 
inhibits the proteasomal degradation of Nrf2 and activates it. Activated Nrf2 directly 
modulates the activity of NADPH generating enzymes, G6PD and 6PGD resulting in 
higher generation of the reducing power and increasing de novo synthesis of GSH by 
modulating the enzyme, GCLC. This leads to the conversion of oxidized GSH (GSSG) to 
reduced GSH and increased accumulation of intracellular GSH which maintains redox 
homeostasis and prevents ZIKV induced cell death.  
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transcription factor inducing the expression of several genes involved in the antioxidant  
response carbohydrate metabolism, lipid metabolism as well as de novo glutathione 
synthesis and NADPH generation (Hayes and Dinkova-Kostova, 2014). With observation 
of oxidative stress induction, we looked for the expression of Nrf2 in ZIKV infected 
cells. A transient upregulation of Nrf2 and its downstream effectors, GCLC and G6PD, 
was seen upon ZIKV infection with time. The temporality of these events preceded the 
marked decrease in cellular GSH pool and the accumulation of ROS. Additionally, with 
the depletion of Nrf2, ZIKV replication was enhanced, as was evident with increased 
viral protein synthesis and infectious virion production, indicating that the cellular 
antioxidant network plays a key role in regulating virus replication. Indeed, inhibition of 
de novo GSH synthesis, an important modulator of redox homeostasis in a cell, by BSO 
enhanced both ZIKV protein expression and infectious viral progeny titers, corroborating 
the observation that cellular antioxidant defense plays an antiviral role in ZIKV 
replication. Cellular viability in Nrf2 depleted or BSO treated, ZIKV-infected cells was 
also significantly reduced due to increased cell death as a result of virus replication.  
Nrf2 directly modulates the cellular reduced GSH pool by regulating key enzymes 
that generate the reducing fuel, NADPH. ZIKV infected cells transiently upregulate Nrf2 
and its downstream effector, G6PD, which along with 6PGD serves to generate NADPH. 
This temporary upregulation leads to increased generation of NADPH that works to 
maintain redox homeostasis in the infected cells. Depletion of either G6PD or 6PDG 
resulted in the enhancement of viral protein expression and progeny virion production 
again corroborating the finding that antioxidant defense system inhibits ZIKV replication.  
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It has been reported previously that replication of several different of viruses such 
as DENV (Chao et al., 2008), entroviruses (Ho et al., 2008), and coronaviruses (Wu et 
al., 2008) is enhanced under conditions of G6PD deficiency. Additionally, individuals 
with genetic deficiency in G6PD have been shown to exhibit more severe complications 
of hepatitis E virus infection (Au et al., 2011; Thapa et al., 2009). Since G6PD enhances 
cellular antiviral response pathways by upregulating certain antiviral genes such as tumor 
necrosis factor a (TNF-a) and myxomavirus resistance 1 (MX1) (Wu et al., 2015), G6PD 
depletion may downregulate antiviral gene expression and support virus replication more 
robustly. Additionally, in G6PD-knowdown cells, expression of HSCARG protein, an 
NADPH sensor, has been demonstrated to be upregulated, which in turn has been shown 
to enhanced antiviral response. Therefore, it is possible that a combination of redox 
imbalance and the inability to generate NADPH and glutathione as well as reduced 
antiviral response due to G6PD depletion may contribute to the increased susceptibility to 
ZIKV infections.      
Interestingly, 6-AN, a known inhibitor of both G6PD or 6PDG did not enhance 
ZIKV replication but in stark contrast to siRNA mediated depletion, significantly reduced 
ZIKV replication as was evident from viral E protein expression and infectious virus 
production. We explored the possibility that supplementing 6-AN treated ZIKV infected 
cells with D-Ribose may antagonize the effect of 6-AN and recover ZIKV protein 
expression. But it was observed that supplementing 6-AN treated ZIKV infected cells 
with D-Ribose did not rescue ZIKV replication, suggesting that the role of PPP is 
dispensable for ZIKV replication in these cells. Additionally, the inhibitory effect of 6-
AN was found to be cell type independent. This suggests that the inhibitory effect of 6-
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AN on ZIKV replication may be by a different mechanism and is not associated with the 
downregulation of enzymes involved in PPP such as G6PD and 6GPD. A detailed 
exploration into the inhibitory mechanism of 6-AN is essential for it to be developed as 
an anti-ZIKV drug. In conclusion, we demonstrate a pivotal role of the Nrf2 signaling 
cascade in ZIKV replication and highlights the antiviral nature of the cascade. This 
observation may lead to the development of antioxidant supplementation as a strategy to 




CHAPTER 5: METABOLIC REGULATION OF ZIKV INFECTION 
 
5.1. Abstract 
Virus infection is known to modulate cellular metabolism which drives cellular 
energetics to a state conducive to viral replication. Increased rate of glycolysis, enhanced 
synthesis of lipids and modifications to lipid membranes, increased production of 
nucleotides and enzymatic cofactors, etc. are hallmark metabolic changes in virus-
infected cells. Therefore, a better understanding of the specific metabolic changes 
induced by virus infection can be useful in the development of antiviral therapies. 
Previous studies have revealed that the pentose phosphate pathway does not appear to 
play a major role in ZIKV replication. To examine if other cellular pathways namely 
glycolysis, gluconeogenesis, or mitochondrial pathways such as fatty acid oxidation, 
glutaminolysis, etc are required for the viral replication, we used pharmacologic 
inhibitors to determine their effect on ZIKV. Results show that inhibition of the rate 
limiting enzyme, hexokinase in the glycolysis pathway, by 2-Deoxy-D-glucose (2-DG), a 
glucose analog, reduced viral protein expression and infectious progeny production. The 
inhibition by 2-DG recovered transiently at 48 h post-infection. This transient recovery 
was prevented when oxidative metabolism was inhibited by blockage of the 
mitochondrial pyruvate carrier, inhibition of fatty acid oxidation, or gluaminolysis. These 
results suggest that gluconeogenesis plays a role in virus replication. Further studies 






The recent re-emergence of ZIKV and the associated serious disease outcomes 
such as microcephaly and other neurological deficits in infants and adults poses a major 
threat to public health (Faizan et al., 2016). While several reports have studied the 
molecular mechanisms involved in the infection, replication, and pathogenesis of ZIKV, 
detailed elucidation of ZIKV-induced metabolic changes is not yet available (Jordan and 
Randall, 2016; Rothan et al., 2019; Thaker et al., 2019b). Generally, virus infection leads 
to enhanced cellular metabolism to meet the biosynthetic needs of viral replication. 
Flavivirus replication is known to increase the production of nucleotides and associated 
enzymatic cofactors (Jordan and Randall, 2016). DENV infection has been reported to 
significantly increase the biosynthesis of carbohydrates, amino acids, and lipids (Fontaine 
et al., 2015; Jordan and Randall, 2016). Furthermore,  DENV infection also increases 
early glycolytic intermediates while decreasing late glycolytic intermediates indicating an 
active glycolytic flux (Allonso et al., 2015; Fontaine et al., 2015). Proteomic analysis of 
HCV-infected Huh-7.5 cells showed perturbations in cellular metabolic pathways namely 
glycolysis, citric acid cycle and the pentose phosphate pathway that favor virus 
replication (Diamond et al., 2010). While this happens early in infection, a shift in 
cellular metabolism towards cell viability and maintaining energy homeostasis is 
observed later in the infection cycle (Diamond et al., 2010).  
Glycolysis is also essential for addition of glycan moieties to proteins for 
glycosylation, the most common form of post translational modifications (Schjoldager et 
al., 2020). Glycosylation of viral proteins is critical to virion assembly, infection as well 
as evasion of immune responses (Annamalai et al., 2019; Annamalai et al., 2017; 
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Watanabe et al., 2019). It has been reported that removal of glycosylation sites from the 
viral envelope (E) and non-structural protein 1 (NS1) of ZIKV leads to attenuation of 
progeny virions and defective in neuroinvasion (Annamalai et al., 2019; Annamalai et al., 
2017; Carbaugh et al., 2019). Furthermore, lipid biosynthesis and intracellular 
accumulation of sphingolipids, phospholipids and cholesterol have been shown to 
facilitate replication of several prototypic flaviviruses such as WNV and DENV (Heaton 
et al., 2010; Mackenzie et al., 2007; Merino-Ramos et al., 2016). DENV activates 
autophagy-mediated lipid catabolism and upregulates β-oxidation and energy metabolism 
that are essential for efficient virus replication (Heaton and Randall, 2010; Khakpoor et 
al., 2009; Lee et al., 2013). Studies with ZIKV have shown that human cells infected with 
ZIKV utilize more glucose and feed into the TCA cycle whereas mosquito cells feed into 
the pentose phosphate pathway suggesting differential metabolic pathways between 
species (Thaker et al., 2019b).  
In this study, we demonstrate that the dependency of ZIKV on glycolysis may be 
indispensable for optimal viral replication. With pharmacological inhibition of glycolysis 
by 2-Deoxy-D-glucose (2-DG), viral protein production and infectious virus yield were 
significantly reduced, although a transient increase at 48 hpi was observed. Glycosylated 
E protein levels were also reduced suggesting an important role for glycolysis in ZIKV 
replication. This observation suggested a virus-induced shift in cellular metabolism 
towards gluconeogenesis. We found that with pharmacological inhibition of the 
mitochondrial pyruvate carrier, fatty acid oxidation or gluaminolysis, a marked reduction 
in viral protein production was noted even at 48 hpi. Taken together, these results suggest 
that glycolysis and gluconeogenesis are needed for optimal replication of ZIKV and 
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demonstrate the complex dependency of ZIKV on cellular metabolism. 
 
5.3. Results 
5.3.1. Glycolysis is necessary for ZIKV protein expression and progeny virion 
production 
Since virus replication is critically dependent on glycolysis for viral protein 
synthesis, post translational modifications of viral proteins, and progeny virion 
production (Watanabe et al., 2019),, we sought to first determine the effect of inhibition 
of glycolysis on ZIKV replication. By using 2-DG to inhibit the activity of hexokinase, 
the enzyme that catalyzes the first irreversible step of the glycolytic pathway where 
glucose is phosphorylated to glucose-6-phosphate (G6P), we found a marked decrease in 
viral E protein expression across all the time points in comparison to cells infected with 
ZIKV and treated with the vehicle (Fig. 5.1A). Interestingly, we observed a transient 
increase in the levels of E proteins at 48 hpi (lane 6) but at later times, the E protein 
levels were reduced (lanes 8 and 10). Several studies have reported the N-glycosylation 
of ZIKV E protein and its importance for viral assembly and infectivity (Annamalai et al., 
2017; Carbaugh et al., 2019; Fontes-Garfias et al., 2017). A follow up study demonstrated 
that the major proportion of N-glycan on ZIKV E include N-acetylglucosamine 
(GlcNAc) and glucose among others (Routhu et al., 2019). Glucose 6P and Fructose 6P, 
two intermediates in glycolytic pathway, are precursors of the nucleotide activated sugars 
donors UDP-glucose and UDP-GlcNac, respectively, that mediate protein N-
glycosylation. Interestingly, we observed that the inhibition of glycolysis by 2-DG 
resulted in the detection of two bands for ZIKV E protein, one representing the fully  
103 
 
Figure 5.1: Glycolysis is necessary for ZIKV protein expression and progeny virion 
production. A A172 cells were either mock-infected (M) or infected with ZIKV at an 
MOI of 1 and treated with vehicle or the glycolytic inhibitor, 2-DG. Cell lysates were 
prepared at the indicated hours post-infection (hpi) and subjected to Western blot analysis 
to detect ZIKV E and β-actin using the corresponding antibodies. Relative electrophoretic 
mobility of molecular mass markers in kD is shown on the right. B Culture supernatants 
from vehicle or 2-DG treated and ZIKV-infected cells were collected every 24 hpi for 
quantitation of virus yield by plaque assay. #, number of plaques were below the limit of 
detection (LOD). **, p≤ 0.01; ****, p≤ 0.0001.  
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glycosylated E protein (top band, identified with a black dot on the left of lane 4) and a 
faster migrating unglycosylated E protein (bottom band, identified with a red dot on the 
left of lane 4) (Fig. 5.1A). The results indicate that exposure of ZIKV infected cells to 2-
DG leads to significant reduction in viral protein levels but also glycosylation of the viral 
E protein.  
Since, viral protein levels as well as glycosylation are critical to the production of 
infectious progeny virions, we examined the yield of infectious virus in the culture 
supernatants of infected cells treated with 2-DG. Results show a dramatic inhibition of 
infectious progeny production at all times examined (Fig. 5.1B). Interestingly, at 96 hpi, 
when E protein was readily detectable (Fig. 5A, lane 10), infectious progeny was 
undetectable (Fig. 5.1B), indicating that factors other than the protein levels or 
glycosylation are important for progeny virus production.  
 
5.3.2. Gluconeogenesis partially contributes to ZIKV replication 
The transient recovery of ZIKV protein synthesis at 48 hpi under condition of 
glycolysis inhibition suggests additional carbon sources are likely fueling viral 
replication. Glucose 6P can also be generated by the recycling of phosphoenolpyruvate 
via gluconeogenesis, which involves carbon metabolism via the mitochondrial TCA 
cycle. Three primary carbon sources can fuel the TCA cycle independent from glycolysis 
are (i) pyruvate, originated by either its reverted synthesis from lactate via lactate 
dehydrogenase or pyruvate uptake from culture media; (ii) fatty acid oxidation (FAO) to 
acetyl-CoA; and (iii3) glutamine lysis (glutaminolysis) to glutamate that is subsequently 
incorporated to the TCA cycle upon its metabolism to α-ketoglutarate. Progressive 
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oxidation of these carbon sources is coupled to the electron transport chain (ETC). In 
addition, reductive carboxylation of pyruvate and glutamine can bypass the ETC to 
produce oxaloacetate/malate that can fuel gluconeogenesis as well (Yip et al., 2016). 
 Therefore, we next evaluated the potential role of mitochondrial metabolism by 
inhibiting the ETC complex I by rotenone (ROT) and the mitochondrial pyruvate carrier 
by UK5099 (UK). A marginal decrease in the levels of viral E proteins was observed 
(Fig. 5.2A). In the presence of ROT or UK, the viral E protein was fully glycosylated 
(lanes 7, 8, 11, and 12). Examining NS1, another viral glycoprotein that is critically 
involved in genome replication, we observed two species of NS1 (glycosylated and 
unglycosylated) in the presence of 2-DG, consistent with our observation with the E 
protein. Significant inhibitory effect production of infectious progeny virions was seen 
with ROT and UK  (Fig. 5.2B). On the other hand, inhibition of FAO by etomoxir (ETO) 
and glutaminolysis by BPTES did not produce any significant effect on viral protein 
synthesis (Fig. 5.3A) or infectious virus yield (Fig. 5.3B). Interestingly, blocking any of 
the pathways that supply carbons to gluconeogenesis under condition of glycolysis 
inhibition resulted in reversal of the transient increase in ZIKV protein expression seen at 
48 hpi when glycolysis was inhibited (Fig. 5.4A and B). These results indicate that when 
glycolysis is inhibited, ZIKV replication is facilitated, albeit in part, by gluconeogenesis.   
 
5.4. Discussion 
Viruses have evolved to alter cellular metabolism for creating an environment 
optimal for their replication in host cells (Jordan and Randall, 2016). The development of  
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Figure 5.2: Inhibition of mitochondrial metabolism affects ZIKV replication. A 
A172 cells were either mock-infected (M) or infected with ZIKV at an MOI of 1 and 
treated with vehicle or 2-DG or mitochondrial ETC complex I inhibitor, Rotenone (ROT) 
or the mitochondrial pyruvate carrier inhibitor, UK5099 (UK). Cell lysates were prepared 
at the indicated hours post-infection (hpi) and subjected to Western blot analysis to detect 
ZIKV E, NS1, and β-actin using the corresponding antibodies. Relative electrophoretic 
mobility of molecular mass markers in kD is shown on the right. B Culture supernatants 
from a similar experiment were collected every 24 hpi for quantitation of virus yield by 
plaque assay. #, number of plaques were below the limit of detection (LOD). *, p≤ 0.05; 
**, p≤ 0.01; ****, p≤ 0.0001.  
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Figure 5.3: Inhibition of fatty acid oxidation or glutaminolysis does not affect ZIKV 
replication. A A172 cells were either mock-infected (M) or infected with ZIKV at an 
MOI of 1 and treated with vehicle or fatty acid oxidation inhibitor, Etomoxir (ETO) or 
glutaminolysis inhibitor, BPTES. Cell lysates were prepared at the indicated hours post-
infection (hpi) and subjected to Western blot analysis to detect ZIKV E and β-actin using 
the corresponding antibodies. Relative electrophoretic mobility of molecular mass 
markers in kD is shown on the right. B Culture supernatants from a similar experiment 
were collected every 24 hpi for quantitation of virus yield by plaque assay. ns, non-
significant. Horizontal dashed lines indicated the limit of detection in plaque assay. **, 
p≤ 0.01; ****, p≤ 0.0001.   
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Figure 5.4: Gluconeogenesis partially regulates ZIKV replication A A172 cells were 
either mock-infected (M) or infected with ZIKV at an MOI of 1 and treated with vehicle 
or 2-DG along with BPTES or ETO or UK. Cell lysates were prepared at 48 hpi and 
subjected to Western blot analysis to detect ZIKV E, NS1, and β-actin using the 
corresponding antibodies. Relative electrophoretic mobility of molecular mass markers in 
kD is shown on the right. B Culture supernatants from a similar experiment were 




metabolomic approaches to study the alterations in cellular metabolism induced by virus 
infection have significantly contributed to a better understanding of the role of 
metabolism in virus infection, replication as well as pathogenesis (Jordan and Randall, 
2016; Sanchez and Lagunoff, 2015). Furthermore, elucidation of specific metabolic 
changes induced by specific viruses has led to the development of antiviral strategies 
targeting host cell processes (Sanchez and Lagunoff, 2015). In this study, we explored the 
role of cellular metabolic pathways and associated signaling cascade in ZIKV protein 
expression and replication. 
  The increase in glycolysis reported in a variety of virus infections demonstrates 
the required surge in cellular bioenergetics in infected cells. Increased glycolysis leads to 
the generation of nucleotides and other cofactors that are involved in the replication of 
the infecting virus. Indeed, in ZIKV infected cells, inhibition of hexokinase, the first 
enzyme of glycolysis, by 2-DG, led to a significant loss in viral protein expression and 
infectious virus titers indicating a strong dependence of ZIKV on cellular glucose 
metabolism. Glycosylation of viral proteins is essential to the production of mature 
infectious virus particles and pathogenesis (Annamalai et al., 2019; Annamalai et al., 
2017; Bagdonaite and Wandall, 2018; Watanabe et al., 2019). The downregulation of 
viral E and NS1 protein glycosylation status demonstrates a two-fold effect of 2-DG on 
inhibition of ZIKV. While blocking the activity of hexokinase by 2-DG reduced ZIKV 
replication, a transient increase in the expression of viral E protein as well as infectious 
virus yield was observed at 48 hpi. This pointed towards the involvement of other carbon 
sources being fed into glucose metabolism via gluconeogenesis (Fig. 5.5).  





Figure 5.5: Cellular metabolism and ZIKV replication. Schematic of cellular 
metabolism showing glycolysis, PPP, TCA cycle and gluconeogenesis (indicated by blue 
arrows). Also shown are the targets for metabolic inhibitors 2-DG, Rotenone (ROT), 
Etomoxir (ETO), BPTES, andUK5099 (UK). When glycolysis is blocked by 2-DG, 
carbons are cycled into the metabolism from pyruvate, fatty acids and glutamine which 




pyruvate carrier by UK led to marginal inhibition of ZIKV protein expression but a more 
pronounced effect on infectious progeny production suggesting a contributing role of 
mitochondrial metabolism in ZIKV replication. In contrast, standalone inhibition of FAO 
by ETO and glutaminolysis by BPTES did not inhibit the accumulation of ZIKV proteins 
suggesting the non-involvement of these metabolic processes in ZIKV replication. 
Furthermore, when any of above mentioned pathways were blocked under condition of 
glycolysis inhibition by 2-DG, the transient increase in ZIKV protein accumulation in 
cells was not observed corroborating the finding that gluconeogenesis plays a 




CHAPTER 6: SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS 
 
6.1 Summary 
Viruses are obligate parasites that co-opt the host cell machinery to synthesize 
their proteins, replicate their genomes, produce progeny virions, and cause disease. On 
the other hand, the host cell also employs several strategies in response to virus infection 
that can be pro- or anti-viral in nature. Therefore, studying the alterations in host cell 
processes induced by virus infection is key to understanding viral pathogenesis as well as 
to the development of antiviral strategies. The studies presented in this dissertation 
demonstrate activation of both mTORC1 and mTORC2 upon ZIKV infection and this 
facilitates viral protein expression and progeny virion production (Fig 6.1). We also 
observed that early in infection, autophagy is activated in ZIKV-infected cells. But later 
in the infection process, a gradual decline in autophagy flux was observed which 
coincided with the activation of mTORC1. The inhibitory effect of mTORC1 on 
autophagy induction was found to be mediated by the phosphorylation of ULK1 (Fig 
6.1). These findings point to an antiviral nature of autophagy induction in ZIKV infected 
cells that is countered by virus-induced activation of mTORC1. Virus infection is also 
known to trigger oxidative stress in infected cells, and this is a critical contributor to 
virus-induced pathogenesis. ZIKV infection was found to induce oxidative stress in 
infected cells which led to a transient activation of Nrf2 mediated antioxidant response. 
Both genetic depletion of Nrf2 and pharmacological inhibition of glutathione (GSH) 
synthesis, led to increased expression of viral proteins and infectious virus production 





Figure 6.1: Host cell responses to ZIKV infection. Nrf2 mediated cellular antioxidant 
system negatively regulates ZIKV replication in infected cells as well as counters virus 
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infection induced oxidative stress at early time points post infection. But at later time 
points, the increased accumulation of viral proteins and replication of ZIKV exerts an 
imbalance in the generation and scavenging of oxidants that leads to cellular damage and 
cell death (upper part of the illustration). ZIKV replication is dependent on cellular 
metabolic processes like glycolysis and gluconeogenesis. Inhibition of glycolysis results 
in significant suppression of ZIKV protein expression and infectious virus yield. But a 
transient increase is observed at 48 hpi because of the activation of gluconeogenesis 
which cycles carbons from sources other than glucose (upper part of the illustration). 
ZIKV infection induces the activation of autophagy that degrades viral proteins at early 
time points thereby resulting in our ability to not detect them. But at later time points, 
activation of the mTORCs phosphorylates ULK1 and suppresses autophagy and this 
leads to increased ZIKV protein expression and progeny production (lower part of the 
illustration).    
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replication, suggesting an anti-viral role of cellular antioxidant system in ZIKV infection. 
Viruses are dependent on cellular metabolism and are known to significantly alter 
them. We found that ZIKV replication in infected cells is heavily dependent on glycolysis 
because the inhibition of glycolysis by 2-DG significantly reduced viral protein 
expression and glycosylation as well as infectious virion production (Fig 6.1). We have 
also demonstrated that upon inhibition of glycolysis, gluconeogenesis contributes to 
ZIKV replication, albeit to a lesser extent. Overall, these findings provide insights into 
the molecular mechanisms regarding mTORCs activation, redox homeostasis and 
metabolic alterations that are involved in ZIKV infection and replication. The major 
conclusions from the above studies are outlined below. 
  
6.2 Conclusions 
1. ZIKV infection induced activation of both mTORCs is necessary for viral protein 
expression and replication. 
2. Autophagy is activated in ZIKV infected cells at early time points post infection 
and blockage of autophagy induction favors ZIKV replication. 
3. ZIKV induced activation of mTORC1 downregulates autophagy which promotes 
ZIKV replication in infected cells. 
4. Increased generation of ROS leads to oxidative stress induction in ZIKV infected 
cells. 




6. Cellular GSH and NADPH are critical players in the antioxidant response to 
ZIKV infection. 
7. Glycolysis is essential to ZIKV protein synthesis and glycosylation and infectious 
progeny production. 
8. ZIKV replication is partially regulated by gluconeogenesis. 
 
6.3 Future directions 
6.3.1 Elucidate the mTOR-independent role of Raptor in ZIKV replication. 
Studies reported in chapter 3 of this dissertation show that while depletion of 
mTOR kinase resulted in still-detectable levels of ZIKV E protein expression and 
progeny production, the siRNA mediated knockdown of Raptor exerted a more robust 
negative effect. Therefore, it would be very interesting to explore the molecular 
mechanisms involved in the mTOR-independent roles of Raptor in ZIKV replication. We 
intend to conduct proteomic analysis of mock- and ZIKV-infected cells and compare the 
interactome of Raptor under both conditions. This approach may help me identify unique 
proteins other than those involved in the mTOR pathway that Raptor interacts with which 
could potentially regulate ZIKV replication.  
 
6.3.2 Which ZIKV proteins are involved in the early activation of autophagy and 
late activation of mTORCs? 
The molecular mechanisms involved in the activation of autophagy in ZIKV 
infected cells are not yet clearly elucidated. While it is shown that NS4A and NS4B 
proteins of ZIKV can induce autophagy (Liang et al., 2016), such observations can be 
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dependent on several factors including the cell type, virus strain as well as the duration of 
infection. While the studies reported in chapter 3 of this dissertation demonstrate 
induction of autophagy early in infection, they do not dissect which viral proteins are 
involved in this process. Upon infection, the structural proteins of ZIKV are responsible 
for the interaction of the infecting virion with the cell surface receptors and subsequent 
internalization. Therefore, it is possible that one or a combination of the structural 
proteins or the viral genome itself, upon uncoating, may trigger autophagy in the infected 
cell. Furthermore, the role of the other NS proteins in the induction of autophagy cannot 
be ruled out. To identify the viral protein(s) that trigger autophagy in ZIKV infected cells, 
we intend to study the effect of ectopic expression of each of the viral proteins. Such a 
study will help identify the viral protein(s) responsible for the early induction of 
autophagy. Additionally, using a similar approach, we plan to identify the viral protein(s) 
that interact with the components of the mTOR signaling pathway leading to its 
activation. The findings from these studies will significantly contribute to the 
understanding of ZIKV induced modulations of cellular signaling pathways. 
 
6.3.3. Explore the effect of ZIKV infection in neuron differentiation using LUHMES 
cells. 
The human neuronal progenitor LUHMES cells are an interesting and 
physiologically relevant model system to study neuron differentiation. These cells can be 
differentiated into mature neurons given the right conditions (Scholz et al., 2011). Studies 
done in chapter 3 and 4 of this dissertation have shown that ZIKV infection activates 
mTOR signaling pathway as well as induces oxidative stress in these cells. While these 
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studies were conducted in undifferentiated LUHMES cells, we intend to determine the 
effect of ZIKV infection induced activation of mTOR cascade and oxidative stress on 
neuronal differentiation and maturation using these cells. By examining specific markers 
of mature neuron development from immature progenitor cells, we hope to dissect the 
mechanisms involved in ZIKV infection induced pathogenesis.  
 
6.3.4. Study the genes involved in causing microcephaly. 
Multiple studies have implicated the involvement of the mTOR signaling pathway 
in the regulation of brain development and induction of microcephaly (Cloetta et al., 
2013; Lipton and Sahin, 2014; Thomanetz et al., 2013). It has also been shown that 
during brain development, the activation of the mTOR pathway is tightly regulated and 
any aberration results in developmental disorders. The MCPH class of proteins (MCPH 
1-27) are known to regulate proper neurological development in fetuses (Siskos et al., 
2021). While the direct involvement of mTOR signaling in modulation of these proteins 
has not yet been studied, it is possible that ZIKV induced activation of mTORCs 
differentially regulates their expression leading to improper brain development and  
neurological disease in infants. Additionally, ZIKV infection could alter the relative 
levels of these proteins leading to imbalances in the ratios of these proteins that may also 
result in microcephaly. Therefore, evaluation of the MCPH group of proteins in ZIKV 
infected cells by RNA-seq analysis as well as by Western blotting can be investigated and 
a possible link between ZIKV induced activation of the mTOR pathway with the 
expression status of the proteins can be established. This will provide important 
information on the molecular mechanisms of ZIKV induced microcephaly. 
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6.3.5. Mechanism of 6-AN induced inhibition of ZIKV. 
The contrasting results obtained by the siRNA mediated depletion and 
pharmacological inhibition, by 6-AN, of PPP enzymes G6PD and 6PGD suggests a PPP-
independent role of 6-AN in the inhibition of ZIKV replication. 6-AN is known to be 
metabolized in cells to 6-amino NAD and 6-amino NADP that act as antimetabolites and 
lead to a depletion of cellular pools of NAD and NADP, both of which are essential for 
the generation of NADPH. Therefore, it would be interesting to study the cellular 
processes, apart from PPP, that are affected by the exposure of cells to 6-AN and how 
such processes contribute to the inhibition of ZIKV replication. This will help elucidate 
the mechanisms involved inhibition of ZIKV by 6-AN. 
 
6.3.6. Metabolomic analysis to determine the changes in cellular metabolism upon 
ZIKV infection. 
The experimental findings described in chapter 5 highlight the dependency of 
ZIKV on cellular metabolic processes, such glycolysis and gluconeogenesis, for its 
replication. While these studies focus on the central carbon metabolism, a holistic 
understanding of overall cellular metabolic alterations induced by ZIKV infection is 
necessary to better understand the dynamics of host-virus interactions, identify unique 
features of virus infection as well as develop novel antiviral strategies. To this end, it 
would be interesting to conduct metabolomic analysis of cells infected with ZIKV and 
compare the metabolomic profile with that of uninfected cells. Such studies will 
significantly contribute to the understanding of host-virus interactions and may provide 
novel targets for drugs against ZIKV infections.  
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6.3.7. How does cellular GSH antagonize ZIKV? 
Studies conducted in chapter 4 show that ZIKV infection causes a Nrf-2-
dependent increase in GCLC which mediates the rate-limiting step in de novo GSH 
formation by the synthesis of its precursor, γ-glutamylcysteine. Cellular GSH is known to 
negatively affect the replication of prototypic flaviviruses such as DENV and ZIKV by 
inhibiting the activity of viral NS5 protein (Saisawang et al., 2018; Tian et al., 2010). 
While such studies have focused on the viral NS5 protein, the effect of glutathionylation 
of other viral proteins on virus replication cannot be overlooked. Therefore, we intend to 
examine the effect of the redox regulated post translational modification, 
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